<SEC-DOCUMENT>0001613103-22-000034.txt : 20220823
<SEC-HEADER>0001613103-22-000034.hdr.sgml : 20220823
<ACCEPTANCE-DATETIME>20220823064724
ACCESSION NUMBER:		0001613103-22-000034
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220823
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220823
DATE AS OF CHANGE:		20220823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medtronic plc
		CENTRAL INDEX KEY:			0001613103
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0428

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36820
		FILM NUMBER:		221185048

	BUSINESS ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		01135314381700

	MAIL ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Ltd
		DATE OF NAME CHANGE:	20150112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Holdings Ltd
		DATE OF NAME CHANGE:	20140711

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kalani I Ltd
		DATE OF NAME CHANGE:	20140709
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mdt-20220823.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1aef31ae-1e30-471a-b48d-f5bf090cf9ba,g:b8c4eebd-78e5-4b47-94dd-98c1c8adc6f9,d:d1db8bc8280f40ffb63a82782c35c134--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mdt="http://www.medtronic.com/20220823" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdt-20220823</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN18yLTEtMS0xLTg4MzMw_7365726c-476d-4797-a1cf-58d517768089">0001613103</ix:nonNumeric><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN18zLTEtMS0xLTg4MzMw_a5c4a1be-8db9-4f83-b6e9-03047a7dadfe">Medtronic plc</ix:nonNumeric><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN180LTEtMS0xLTg4MzMw_324765b8-98fc-4b61-ba86-e87c81b6ff09">D02 XH02</ix:nonNumeric><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN181LTEtMS0xLTg4MzMw_b30043bf-722b-4454-a1dd-94de86cec9b6">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdt-20220823.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3afecaea79784f64820dd39c3de82568_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62e40b0d60f74b66beb6116092511379_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.00PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20391.50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-23</xbrli:startDate><xbrli:endDate>2022-08-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id1db8bc8280f40ffb63a82782c35c134_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.&#160;20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV8xMTU_5abae5f9-8d8d-4045-aabb-15ebb761039b">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV81NDk3NTU4MTU3Njg_35863908-b249-4191-8738-8227c9b5d711">August 23, 2022</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________&#160;</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in its Charter)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmY3NmFkYWNlY2RmNDUxYmI1ZDY5Y2U1ZmIyN2ZiOWUvdGFibGVyYW5nZTpiZjc2YWRhY2VjZGY0NTFiYjVkNjljZTVmYjI3ZmI5ZV8xLTAtMS0xLTg4MzMw_e28ed376-c672-41d8-9b63-708f6ac60846">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmY3NmFkYWNlY2RmNDUxYmI1ZDY5Y2U1ZmIyN2ZiOWUvdGFibGVyYW5nZTpiZjc2YWRhY2VjZGY0NTFiYjVkNjljZTVmYjI3ZmI5ZV8xLTItMS0xLTg4MzMw_5056ace2-4e83-4f19-aa18-5de3dd00fd07">1-36820</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmY3NmFkYWNlY2RmNDUxYmI1ZDY5Y2U1ZmIyN2ZiOWUvdGFibGVyYW5nZTpiZjc2YWRhY2VjZGY0NTFiYjVkNjljZTVmYjI3ZmI5ZV8xLTQtMS0xLTg4MzMw_008a770c-3f65-4e2a-8e08-dab2ca3ca359">98-1183488</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80Mjg_977656c5-c53e-43a2-bbf3-816abd0ecf6e">20 On Hatch, Lower Hatch Street</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80MzI_2da2e861-9df4-4bef-a7ed-cdb9e756ac38">Dublin 2</ix:nonNumeric>, <ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80MzY_124df11e-d5ec-49e0-8aa6-eb2f85dda198">Ireland</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80OTQ_c9ffd38f-4489-43c0-9633-379bc9ef0f84">353</ix:nonNumeric> <ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80OTc_f4832577-8426-4b6d-bbac-30265065a15c">1</ix:nonNumeric> <ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV81MDA_d907bd35-169c-4c97-b37d-c6de75a16c09">438-1700</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Registrant&#8217;s telephone number, including area code)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former name or former address, if changed since last report </span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6OTE2NjlkYzgwMjA4NDMzNWE5OGEyM2MyZmU0NGRiZTAvdGFibGVyYW5nZTo5MTY2OWRjODAyMDg0MzM1YTk4YTIzYzJmZTQ0ZGJlMF8wLTAtMS0xLTg4MzMw_1f52b516-63d4-40ec-b2e8-a961315489c6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmRkMTc0NjVhYzdkNGFhMDg2Mjk1NzNmY2QzOGQ0NTYvdGFibGVyYW5nZTpiZGQxNzQ2NWFjN2Q0YWEwODYyOTU3M2ZjZDM4ZDQ1Nl8wLTAtMS0xLTg4MzMw_ff72aa02-160c-4559-b3ed-113fcdc450c6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6MWRmM2YzMWQ0YzI4NDI4YTgzOTViOGY1YmNlNTViNTAvdGFibGVyYW5nZToxZGYzZjMxZDRjMjg0MjhhODM5NWI4ZjViY2U1NWI1MF8wLTAtMS0xLTg4MzMw_e8c32c95-a474-414c-912e-26223e76ca2a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6MTA0NDEzMWI2MTk4NDgxOTg1NDI4OTZlYzc1NzQwYmIvdGFibGVyYW5nZToxMDQ0MTMxYjYxOTg0ODE5ODU0Mjg5NmVjNzU3NDBiYl8wLTAtMS0xLTg4MzMw_47838a11-9485-461d-a7ab-b4cfcb4b633a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xLTAtMS0xLTg4MzMw_9b1962fe-2a04-42b8-bc9d-e91036c2843b">Ordinary shares, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xLTEtMS0xLTg4MzMw_0380b738-514f-48cc-b57f-05bf5d5d767b">MDT</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xLTItMS0xLTg4MzMw_e5bb8638-b22c-4d54-b3cc-764bc553214e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8yLTAtMS0xLTg4MzMw_d8e514d9-63ff-425f-88b8-0e8bce98e0b7">0.00% Senior Notes due 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8yLTEtMS0xLTg4MzMw_55cb78ba-e70d-4de3-a07d-517c5d4b3e94">MDT/22B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8yLTItMS0xLTg4MzMw_07f91c62-d2c7-4629-9aa5-f62da9f48184">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3afecaea79784f64820dd39c3de82568_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8zLTAtMS0xLTg4MzMw_8a1822e4-6e74-4400-b6c2-817c7835c912">0.375% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3afecaea79784f64820dd39c3de82568_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8zLTEtMS0xLTg4MzMw_1f2475d6-4e1b-43de-860e-3f27f4b91c31">MDT/23B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3afecaea79784f64820dd39c3de82568_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8zLTItMS0xLTg4MzMw_895d1767-7141-4719-9b08-4cd053f8ca62">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV80LTAtMS0xLTg4MzMw_7fd9e457-8327-41c5-b092-5f3b4cbc3c96">0.000% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV80LTEtMS0xLTg4MzMw_9af82e07-25c3-45b5-ac61-57d8b60f8a33">MDT/23C</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV80LTItMS0xLTg4MzMw_8d9d556e-a979-4e06-bae1-78bc0478726d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV81LTAtMS0xLTg4MzMw_6302aaf0-1920-40dc-b0a7-3ec8c90728d5">0.25% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV81LTEtMS0xLTg4MzMw_d9dcf2d0-e635-496d-9a5b-e8fc0e7c7ea8">MDT/25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV81LTItMS0xLTg4MzMw_67e49451-b41b-44d0-87e9-c20309a245ed">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV82LTAtMS0xLTg4MzMw_02e7380a-28c3-43d2-a01d-26a8f6d16a34">0.000% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV82LTEtMS0xLTg4MzMw_589801f0-ba6a-4240-860f-5ad727fb4fa8">MDT/25A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV82LTItMS0xLTg4MzMw_574b7a83-13ed-4e30-ad6c-3db9343df6c6">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV83LTAtMS0xLTg4MzMw_640501d9-3958-4a75-b5a5-83406dece793">1.125% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV83LTEtMS0xLTg4MzMw_f084067c-3f1d-4dde-bfd9-b4df2151c06a">MDT/27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV83LTItMS0xLTg4MzMw_612d7678-57fa-460e-b50d-e1e7e92e000b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV84LTAtMS0xLTg4MzMw_2aaec3c1-eb86-41c4-b67b-cbc2ded897df">0.375% Senior Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV84LTEtMS0xLTg4MzMw_a03327cc-3aba-4a29-b95b-1c01be45447f">MDT/28</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV84LTItMS0xLTg4MzMw_d2db4217-1619-41a4-8656-c41a1c2b8581">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV85LTAtMS0xLTg4MzMw_6b50028c-0bda-4ae7-89bd-5fc5af7467dc">1.625% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV85LTEtMS0xLTg4MzMw_97c85e93-0398-4d8e-b424-01d3c7d88148">MDT/31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV85LTItMS0xLTg4MzMw_8caacbae-c61c-40f3-a83a-b344022afbb7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62e40b0d60f74b66beb6116092511379_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMC0wLTEtMS04ODMzMA_80bd5696-4cf1-48be-bdbd-2d6f9affe445">1.00% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62e40b0d60f74b66beb6116092511379_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMC0xLTEtMS04ODMzMA_3f3b9d1c-eb33-46b8-9642-8e15296c6021">MDT/31A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i62e40b0d60f74b66beb6116092511379_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMC0yLTEtMS04ODMzMA_b7cfb81e-da99-48f4-8d11-0235e47a1069">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMS0wLTEtMS04ODMzMA_227529a3-b026-4b8d-ad45-c0e273e855ac">0.750% Senior Notes due 2032</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMS0xLTEtMS04ODMzMA_9c4f00a6-9d14-41ec-906e-9ad27b2530d0">MDT/32</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMS0yLTEtMS04ODMzMA_6d038717-e522-4b9a-ae7b-89bc5499f42f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMi0wLTEtMS04ODMzMA_9cda6d8c-03e6-4007-adf7-848964928788">2.250% Senior Notes due 2039</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMi0xLTEtMS04ODMzMA_15b1d66d-5d6d-4d66-8b40-068377d2b3a4">MDT/39A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMi0yLTEtMS04ODMzMA_936a30d9-e0ec-494d-bf87-7a6fdbe74bd9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMy0wLTEtMS04ODMzMA_27322f16-580a-4bb4-a582-11f50d8a751d">1.50% Senior Notes due 2039</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMy0xLTEtMS04ODMzMA_3ee8c3b6-1b32-4143-90dc-9aa0fa46f68e">MDT/39B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMy0yLTEtMS04ODMzMA_6723ff3c-a20b-495e-ae66-e47657a901aa">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNC0wLTEtMS04ODMzMA_d8a2fc1b-7bd9-4adb-ba36-714163dc22c5">1.375% Senior Notes due 2040</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNC0xLTEtMS04ODMzMA_88dbafd1-bfb7-4cbb-8fe5-1ee6fa925d25">MDT/40A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNC0yLTEtMS04ODMzMA_93250aab-e78a-40e2-9767-1a66defc9198">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNS0wLTEtMS04ODMzMA_e842e2c3-7ccf-438f-9d14-e373f48cf377">1.75% Senior Notes due 2049</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNS0xLTEtMS04ODMzMA_fed4a5d5-7e04-471d-b293-3cfc5b9ffbba">MDT/49</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNS0yLTEtMS04ODMzMA_472872fa-af11-4333-82c2-a47a7efb06d8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNi0wLTEtMS04ODMzMA_3becf04c-7cb7-4941-95a6-43632c79d807">1.625% Senior Notes due 2050</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNi0xLTEtMS04ODMzMA_b5638204-2622-4d5f-ab26-da8c519812d5">MDT/50</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNi0yLTEtMS04ODMzMA_fdc35b51-649a-4a53-911a-ac37bf042ce7">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV8xMDc2_d8ff57df-3c0b-4860-b799-fd8bc7d1ae67">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.02.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2022, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its first quarter fiscal year 2023 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.01.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) List of Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:14.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-fy23q1earningsr.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-fy23q1earningsr.htm">Press release of Medtronic plc, </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-fy23q1earningsr.htm">dated August 23, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (embedded with the Inline XBRL document).</span></div></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.752%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medtronic plc</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Karen L. Parkhill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen L. Parkhill</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT INDEX</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-fy23q1earningsr.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-fy23q1earningsr.htm">Press release of Medtronic plc,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-fy23q1earningsr.htm"> dated August 23, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (embedded with the Inline XBRL document).</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-fy23q1earningsr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_619"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:263px"></div><div style="text-align:right"><font style="color:#140f4b;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEWS RELEASE</font></div><div><font><br></font></div><div><font style="color:#140f4b;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Contacts&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Erika Winkels</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ryan Weispfenning</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Public&#160;Relations</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investor&#160;Relations</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">+1-763-526-8478</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">+1-763-505-4626</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#140f4b;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#1010eb;font-family:'Arial',sans-serif;font-size:20pt;font-weight:400;line-height:174%">Medtronic reports first quarter</font></div><div style="text-align:center"><font style="color:#1010eb;font-family:'Arial',sans-serif;font-size:20pt;font-weight:400;line-height:174%">fiscal 2023 financial results</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Revenue exceeds guidance, with known supply chain challenges impacting results&#59; notable strength in Pacing, Cardiac Surgery, Core Spine in the U.S., and Diabetes in Europe</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%">DUBLIN &#8211; Aug. 23, 2022 &#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> Medtronic plc (NYSE&#58;MDT) today announced financial results for its first quarter of fiscal year 2023, which ended July 29, 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Key Highlights</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:13.8pt">GAAP diluted EPS of $0.70 increased 25%&#59; non-GAAP diluted EPS of $1.13 decreased 17%, in-line with expectations</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:13.8pt">Revenue of $7.4 billion decreased 8% as reported and 4% organic, ahead of expectations</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:13.8pt">Company reiterates FY23 revenue and EPS guidance</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The company reported worldwide revenue of $7.371 billion, a decrease of 8% as reported and 4% on an organic basis. The organic comparison excludes a $351 million </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">negative impact from foreign currency translation and a $20 million contribution from the company&#8217;s recent acquisition of Intersect ENT, which is reported in the Specialty Therapies division in the Neuroscience Portfolio. Unless otherwise stated, all revenue growth rates in this press release are on an organic basis, which excludes the impact of foreign currency translation and revenue from the Intersect ENT acquisition. The company&#8217;s first quarter organic revenue results reflect the impact of known supply chain shortages, as well as unfavorable comparisons to the prior year given last year&#8217;s strong ventilator sales and market procedure recovery following the third COVID-19 wave.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">As reported, first quarter GAAP net income and diluted earnings per share (EPS) were $929 million and $0.70, respectively, increases of 22% and 25%, respectively. As detailed in the financial schedules included at the end of this release, first quarter non-GAAP net income and non-GAAP diluted EPS were $1.502 billion and $1.13, respectively, decreases of 18% and 17%, respectively. The company&#8217;s earnings reflect the continued impact to certain procedure volumes and the macroeconomic impacts of inflation and foreign currency translation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">First quarter U.S. revenue of $3.766 billion represented 51% of company revenue and decreased 8% as reported and 9% organic. Non-U.S. developed market revenue of $2.328 billion represented 32% of company revenue and decreased 10% as reported and increased 2% organic. Emerging Markets revenue of $1.276 billion represented 17% of company revenue and decreased 1% as reported and increased 2% organic.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8220;The company continues to execute in a challenging environment, delivering organic revenue above our guidance,&#8221; said Geoff Martha, Medtronic chairman and chief executive officer. &#8220;</font><font style="color:#3c3c3c;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">As we look ahead, our supply chain is improving, we have several near-term pipeline catalysts approaching, and we are confident in our ability to accelerate growth.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;  </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Cardiovascular Portfolio</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Cardiovascular Portfolio includes the Cardiac Rhythm &#38; Heart Failure (CRHF), Structural Heart &#38; Aortic (SHA), and Coronary &#38; Peripheral Vascular (CPV) divisions. Cardiovascular revenue of $2.713 billion decreased 6% as reported and 1% organic, with low-single digit declines in CRHF and CPV and flat year-over-year results in SHA, all on an organic basis.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Cardiac Rhythm &#38; Heart Failure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $1.393 billion decreased 6% as reported and 1% organic. Cardiac Rhythm Management revenue decreased low-single digits, with high-single digit declines in Defibrillation Solutions partially offset by mid-single digit growth in Cardiac Pacing Therapies, driven by mid-teens growth in Leadless Pacemakers from continued global adoption of Micra&#8482; transcatheter pacing systems. Cardiovascular Diagnostics revenue increased low-single digits, as procedures remain under pressure market-wide. Cardiac Ablation Solutions revenue decreased low-single digits as a result of supply constraints in Western Europe, and COVID lockdowns in China.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Structural Heart &#38; Aortic</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $741 million decreased 6% as reported and was flat year-over-year organic. Structural Heart decreased low-single digits, including low-single digit growth in transcatheter aortic valves (TAVR). Aortic declined mid-single digits given continued supply challenges. Cardiac Surgery increased mid-single digits, driven by strength in extracorporeal life support products and sales of the Avalus&#8482; pericardial aortic surgical valve.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Coronary &#38; Peripheral Vascular</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $579 million decreased 7% as reported and low-single digits organic. Coronary &#38; Renal Denervation (CRDN) decreased mid-single digits, given the ongoing impact of COVID-19 on percutaneous coronary intervention (PCI) market procedures in many geographies. Peripheral Vascular Health decreased low-single digits, with declines in directional atherectomy and PTA balloons partially offset by growth in drug-coated balloons, vascular embolization, and superficial venous products.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Medical Surgical Portfolio</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Medical Surgical Portfolio includes the Surgical Innovations (SI) and the Respiratory, Gastrointestinal &#38; Renal (RGR) divisions. Medical Surgical revenue of $2.001 billion decreased 14% as reported and 9% organic, with high-single digit declines in both SI and RGR. Excluding the impact of ventilator sales given the increased COVID-19 related demand in the prior year, Medical Surgical revenue decreased 7% organic.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Surgical Innovations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $1.338 billion decreased 14% as reported and 9% organic. The division had low-double digit declines in Advanced Surgical Instruments given expected acute supply chain shortages of raw materials, and the impact of China COVID lockdowns and provincial value-based procurement (VBP) stapling tenders. These declines were partially offset by strength in Hernia &#38; Wound Management, which increased mid-single digits.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Respiratory, Gastrointestinal &#38; Renal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $664 million decreased 14% as reported and 9% organic. RGR revenue decreased 3% organic excluding the impact of ventilator sales. Respiratory Interventions decreased mid-twenties, with sales of ventilators declining low-fifties as demand was well below pre-pandemic levels. Patient Monitoring increased low-single digits, with low-single digit declines in Nellcor&#8482; pulse oximetry products offset by mid-single digit growth in Perioperative Complications products. Gastrointestinal revenue decreased low-single digits, with high-single digit declines in esophageal products partially offset by mid-single digit growth in chronic and colorectal products. Renal Care Solutions decreased low-double digits given product holds and supply chain challenges.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Neuroscience Portfolio</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Neuroscience Portfolio includes the Cranial &#38; Spinal Technologies (CST), Specialty Therapies, and Neuromodulation divisions. Neuroscience revenue of $2.115 billion </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">decreased 4% as reported and 2% organic, with mid-single digit declines in CST and Neuromodulation, partially offset by mid-single digit increases in Specialty Therapies, all on an organic basis.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Cranial &#38; Spinal Technologies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $1.043 billion decreased 7% as reported and 5% organic. Spine &#38; Biologics decreased mid-single digits, with mid-teens declines in Biologics given customer ordering patterns, partially offset by mid-single digit Core Spine growth in the United States. Neurosurgery declined low-single digits, with declines in navigation and robotics partially offset by growth in powered surgical instruments, imaging, and CSF management.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Specialty Therapies </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">revenue of $667 million increased 4% as reported and organic. Neurovascular increased low double-digits driven by strength in hemorrhagic stroke products. Pelvic Health decreased low-single digits on competitive pressures. ENT was flat year-over-year on an organic basis given supply constraints on several product lines.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;padding-left:13.8pt">Neuromodulation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> revenue of $405 million decreased 8% as reported and 5% organic. Brain Modulation decreased low-single digits, as significant declines of replacement devices were partially offset by increased share of initial implants from the continued adoption of the Percept&#8482; PC deep brain stimulation (DBS) system and SenSight&#8482; directional DBS lead system. Pain Therapies decreased high-single digits, with mid-single digit declines in both Interventional and Pain Stim, as well as low-double digit declines in Targeted Drug Delivery on a difficult comparison given a supply recovery in the prior year. The Pain Stim market remained under pressure given healthcare staffing challenges and higher payer pre-authorizations. At the same time, the company continued to win new implant share in Pain Stim on strong adoption of&#160;its Vanta&#8482; and&#160;Intellis&#8482; with DTM&#8482; SCS neurostimulators.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Diabetes</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Diabetes revenue of $541 million decreased 5% as reported and was flat year-over-year organic. U.S. revenue declined mid-teens, given the absence of new product approvals. This was offset by low-double digit organic growth in non-U.S. developed markets and mid-teens organic growth in emerging markets. International sales were driven by mid-twenties growth in sales of continuous glucose monitoring (CGM) products and low-double digit growth in consumable sales, offset by low-single digit declines in sales of durable insulin pumps.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Guidance</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The company today reiterated its revenue growth and EPS guidance ranges for fiscal year 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The company continues to expect organic revenue growth in its fiscal year 2023 in the range of 4% to 5%. If recent foreign currency exchange rates hold, fiscal year 2023 revenue growth would be negatively affected by approximately $1.4 billion to $1.5 billion versus the previously stated $1.0 to $1.1 billion impact.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The company continues to expect fiscal year 2023 diluted non-GAAP EPS in the range of $5.53 to $5.65, including an estimated 17 to 22 cent negative impact from foreign currency.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8220;While our markets are facing macroeconomic challenges, we&#8217;re focused on identifying ways to offset their impact to our financials,&#8221; said Karen Parkhill, Medtronic chief financial officer. &#8220;Looking ahead, we expect organic revenue growth to improve each quarter, with the second half of the fiscal year much stronger than the first. We are optimistic about our future, as we create markets and realize new opportunities.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Webcast Information</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Medtronic will host a webcast today, August 23, at 8&#58;00 a.m. EDT (7&#58;00 a.m. CDT) to provide information about its businesses for the public, investors, analysts, and news </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">media. This webcast can be accessed by clicking on the Events icon at </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">investorrelations.medtronic.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> and this earnings release will be archived at </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">news.medtronic.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">. Medtronic will be live tweeting during the webcast on its Newsroom Twitter account, </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">&#64;Medtronic</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">. Within 24 hours of the webcast, a replay of the webcast and transcript of the company&#8217;s prepared remarks will be available by clicking on the Events icon at </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">investorrelations.medtronic.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Medtronic plans to report its fiscal year 2023 second, third, and fourth quarter results on November 22, 2022, February 21, 2023, and Thursday, May 25, 2023, respectively. Confirmation and additional details will be provided closer to the specific event.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">Financial Schedules </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The first quarter financial schedules and non-GAAP reconciliations can be viewed by clicking on the Investor Events link at </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">investorrelations.medtronic.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%;text-decoration:underline">About Medtronic</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission &#8212; to alleviate pain, restore health, and extend life &#8212; unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE&#58;MDT), visit </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">www.Medtronic.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> and follow </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">&#64;Medtronic</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> on Twitter and </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%;text-decoration:underline">FORWARD LOOKING STATEMENTS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the company&#8217;s periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words or expressions, such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;looking ahead,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;going to,&#8221; &#8220;will,&#8221; and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%;text-decoration:underline">NON-GAAP FINANCIAL MEASURES</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">This press release contains financial measures, including adjusted net income, adjusted diluted EPS, and organic revenue, which are considered &#8220;non-GAAP&#8221; financial measures under applicable SEC rules and regulations. References to quarterly figures increasing, decreasing or remaining flat are in comparison to fiscal year 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Medtronic management believes that non-GAAP financial measures provide information useful to investors in understanding the company&#8217;s underlying operational performance and trends and to facilitate comparisons with the performance of other companies in the med tech industry. Non-GAAP net income and diluted EPS exclude the effect of certain charges or gains that contribute to or reduce earnings but that result from transactions or events that management believes may or may not recur with similar materiality or impact to operations in future periods (Non-GAAP Adjustments). Medtronic generally uses non-GAAP financial measures to facilitate management&#8217;s review of the operational performance of the company and as a basis for strategic planning. Non-GAAP financial measures should be considered supplemental to and not a substitute for financial information prepared in accordance with U.S. generally accepted accounting principles (GAAP), and investors are cautioned that Medtronic may calculate non-GAAP financial measures in a way that is different from other companies. Management strongly encourages investors to review the company&#8217;s consolidated financial statements and publicly filed reports in their entirety. Starting with the quarter ended April 29, 2022, the Company no longer adjusts non-GAAP financial measures for certain license payments for, or acquisitions of, technology not approved by regulators. Historical non-GAAP financial measures have been recast for comparability. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the financial schedules accompanying this press release.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Medtronic calculates forward-looking non-GAAP financial measures based on internal forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking organic revenue growth guidance excludes the impact of foreign currency fluctuations, as well as significant acquisitions or divestitures. Forward-looking diluted non-GAAP EPS guidance also excludes other potential charges or gains that would be recorded as Non-GAAP Adjustments to earnings during the fiscal year. Medtronic does not attempt to provide reconciliations of forward-looking non-GAAP EPS guidance to projected GAAP EPS guidance because the combined impact and timing of recognition of these potential charges or gains is inherently uncertain and difficult to predict and is unavailable without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors. Such items could have a substantial impact on GAAP measures of financial performance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">-end-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:93.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">FINANCIAL SCHEDULES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">World Wide Revenue</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">11</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Revenue</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">12</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">World Wide Revenue&#58; Geographic</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">13</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Statements of Income</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">14</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP to Non-GAAP Reconciliations</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">15</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Balance Sheets</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">18</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Statements of Cash Flows</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#icc051c9c7f784c4f8e9b31bcdf86fbaa_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">19</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_10"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WORLD WIDE REVENUE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.510%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FIRST QUARTER</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">REPORTED</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSTANT CURRENCY</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY23</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY22</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Growth </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency Impact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY23</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Growth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,713</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,890</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6.1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(138)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,851</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardiac Rhythm &#38; Heart Failure</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,393&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,483&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(71)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,464&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Structural Heart &#38; Aortic </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">741&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">787&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">784&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Coronary &#38; Peripheral Vascular </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">579&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">604&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Surgical </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,322</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,116</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical Innovations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,554&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(82)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,420&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &#38; Renal</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">664&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">768&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.5)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,115</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,204</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(64)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,179</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cranial &#38; Spinal Technologies</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,043&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,123&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,071&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Specialty Therapies </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">667&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">641&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">689&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neuromodulation </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">405&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">440&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.5)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">541</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">572</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(33)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">574</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,371</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,987</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(351)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,722</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) The currency impact to revenue measures the change in revenue between current and prior year periods using constant exchange rates.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) The first quarter of 2023 includes $20 million of inorganic revenue related to the Intersect ENT acquisition, which is included in the reported results of the Specialty Therapies division of the Neuroscience portfolio. When excluding the impact of currency and the inorganic Intersect ENT revenue, first quarter 2023 revenue declined approximately 3.6 percent organic.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_13"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REVENUE</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.962%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.962%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.966%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FIRST QUARTER</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">REPORTED</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY23</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY22</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Growth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,298</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,420</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8.6)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardiac Rhythm &#38; Heart Failure</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Structural Heart &#38; Aortic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">347&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Coronary &#38; Peripheral Vascular</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Surgical</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">843</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">990</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical Innovations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &#38; Renal</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,419</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,446</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cranial &#38; Spinal Technologies</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">762&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Specialty Therapies</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">380&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">360&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neuromodulation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">276&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">291&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">206</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">245</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,766</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,101</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) U.S. includes the United States and U.S. territories.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) The first quarter of 2023 includes $20 million of inorganic revenue related to the Intersect ENT acquisition, which is included in the reported results of the Specialty Therapies division of the Neuroscience portfolio. When excluding the impact of currency and the inorganic Intersect ENT revenue, first quarter 2023 revenue declined approximately 8.7 percent organic.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_16"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WORLD WIDE REVENUE&#58; GEOGRAPHIC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FIRST QUARTER</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">REPORTED</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSTANT CURRENCY</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY23</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY22</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Growth</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency Impact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FY23</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Growth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,298&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,420&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.6)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,298&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.6)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. Developed</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">892</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,003</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(122)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,014</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging Markets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">523</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular </font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,713</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,890</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(138)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,851</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">843</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">843</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. Developed</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">871</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging Markets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">463</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">403</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Surgical </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,322</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13.8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(115)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,116</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,419</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,446</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,419</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. Developed</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">407</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">463</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging Markets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,115</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,204</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(64)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,179</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. Developed</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">264</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging Markets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes </font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">541</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">572</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(33)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">574</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,766</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,101</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,766</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. Developed</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,328</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,601</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(315)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,643</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging Markets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,276</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,286</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,311</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,371</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,987</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(351)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,722</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) U.S. includes the United States and U.S. territories. Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries of Western Europe. Emerging Markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as previously defined. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) The currency impact to revenue measures the change in revenue between current and prior year periods using constant exchange rates.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) The first quarter of 2023 includes $20 million of inorganic revenue related to the Intersect ENT acquisition, which is included in the reported results of the Specialty Therapies division of the Neuroscience portfolio. When excluding the impact of currency and the inorganic Intersect ENT revenue, first quarter 2023 revenue declined approximately 3.6 percent organic.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_19"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.707%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 29, 2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 30, 2021</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,371&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs and expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold, excluding amortization of intangible assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to noncontrolling interests</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Medtronic</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</font></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329.4&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.5&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average shares outstanding</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_25"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP TO NON-GAAP RECONCILIATIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:31.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.176%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.152%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.152%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="51" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended July 29, 2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost of Products Sold</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Margin Percent</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating Profit Percent</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Diluted </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">EPS</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Tax Rate</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,371&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,516&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,125&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,044&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">929&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.70&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP Adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:5.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and associated costs (2)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:5.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition-related items (3)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:5.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)&#47;loss on minority investments (4)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical device regulations (5)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">359&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.27&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RCS impairments &#47; costs (6)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt redemption premium and other charges (7)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain tax adjustments, net (8)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.01)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,371&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,467&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,765&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,734&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.13&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency impact</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Adjusted</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,722&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,549&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,815&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.16&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended July 30, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost of Products Sold</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Margin Percent</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating Profit Percent</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Diluted </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">EPS</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Tax Rate</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,987&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,598&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">859&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">763&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.56&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP Adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and associated costs (2)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition-related items (1) (3)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain litigation charges</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:5.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)&#47;loss on minority investments (4)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(29)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.02)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical device regulations (5)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MCS impairments &#47; costs (9)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">726&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">726&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">564&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.42&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain tax adjustments, net (10)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP (1)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,987&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,491&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68.8&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,168&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.1&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,111&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,838&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.36&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:2pt;margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">See description of non-GAAP financial measures contained in the press release dated August&#160;23, 2022.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The data in this schedule has been intentionally rounded to the nearest million or $0.01 for EPS figures, and, therefore, may not sum. Starting with the quarter ended April 29, 2022, the Company will no longer adjust non-GAAP financial measures for certain license payments for, or acquisitions of, technology not approved by regulators due to recent industry guidance from the U.S. Securities and Exchange Commission. Historical non-GAAP financial measures presented in our earnings release have been recast for comparability. </font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges primarily include business combination costs and changes in fair value of contingent consideration.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be duplicative of previously incurred costs and&#47;or one-time costs, which are limited to a specific time period. </font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges predominantly include non-cash pre-tax impairments, primarily related to goodwill, as a result of the anticipated sale of half of the Company's Renal Care Solutions (RCS) business related to the May 25, 2022 agreement with DaVita Inc.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges relate to the early redemption of approximately $2.3 billion of debt and were recorded within </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%">interest expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%"> within the consolidated statements of income. </font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The net benefit is due to a valuation allowance release associated with certain carryover attributes as a result of the anticipated RCS transaction listed above in (6) partially offset by the amortization of previously established deferred tax assets from intercompany intellectual property transactions.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges relate to the Company&#8217;s June 2021 decision to stop the distribution and sale of the Medtronic HVAD System within the Mechanical Circulatory Support Operating Unit (MCS). The charges included $515 million of non-cash impairments, primarily related to $409 million of intangible asset impairments, as well as $211 million for commitments and obligations in connection with the decision, including customer support obligations, restructuring, and other associated costs. Medtronic is committed to serving the needs of the approximately 3,200 patients currently implanted with the HVAD System.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:5.02pt">The charges are associated with a change in the company&#8217;s permanently reinvestment assertion on certain historical earnings and the amortization on previously established deferred tax assets from intercompany intellectual property transactions.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_31"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP TO NON-GAAP RECONCILIATIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="45" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended July 29, 2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">SG&#38;A Expense</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">SG&#38;A Expense as a % of Net Sales</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">R&#38;D Expense</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">R&#38;D Expense as a % of Net Sales</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Operating Expense (Income), net</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Operating Expense, net as a % of Net Sales</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Non-Operating (Income) Expense, net</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,371&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,567&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">692&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP Adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and associated costs (2)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition-related items (3)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical device regulations (4)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RCS impairments &#47; costs (5)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(68)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain&#47;(loss) on minority investments (6)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,371&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">678&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(57)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency impact</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Adjusted</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,722&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,613&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.8&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See description of non-GAAP financial measures contained in the press release dated August&#160;23, 2022.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The charges primarily include business combination costs and changes in fair value of contingent consideration.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be duplicative of previously incurred costs and&#47;or one-time costs, which are limited to a specific time period. </font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;padding-left:8.92pt">The charges predominantly include non-cash pre-tax impairments, primarily related to goodwill, as a result of the anticipated sale of half of the Company's Renal Care Solutions (RCS) business related to the May 25, 2022 agreement with DaVita Inc.</font></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations. </font></div><div style="margin-bottom:4pt;text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_34"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP TO NON-GAAP RECONCILIATIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.930%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 29, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 30, 2021</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,292&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to property, plant, and equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(426)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(378)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Free Cash Flow (2)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">657&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">914&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See description of non-GAAP financial measures contained in the press release dated August&#160;23, 2022.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Free cash flow represents operating cash flows less property, plant, and equipment additions. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_37"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 29, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,714&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less allowances and credit losses of $219 and $230, respectively</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,551&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,809&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,616&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,145&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,135&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,059&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,323&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,365&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,043)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,952)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,281&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,413&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,324&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,502&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other intangible assets, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,775&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,595&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,311&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,008&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,914&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,981&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LIABILITIES AND EQUITY</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,729&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,816&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,551&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,049&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,394&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,372&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued compensation and retirement benefits</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,071&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,260&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares&#8212; par value  $0.0001, 2.6 billion shares authorized, 1,329,276,973 and 1,330,743,395 shares issued and outstanding, respectively</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,335&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,566&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,276&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,250&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,939)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,265)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,672&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,551&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,843&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,722&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,914&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,981&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><div id="icc051c9c7f784c4f8e9b31bcdf86fbaa_40"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDTRONIC PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 29, 2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 30, 2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCS asset impairment and inventory write-down</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of acquisitions and divestitures&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(416)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating assets and liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,191)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property, plant, and equipment</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,884)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,654)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,585)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings (maturities greater than 90 days)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on long-term debt</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,311)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends to shareholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(846)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ordinary shares</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(950)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,055)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,714&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mdt-20220823.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1aef31ae-1e30-471a-b48d-f5bf090cf9ba,g:b8c4eebd-78e5-4b47-94dd-98c1c8adc6f9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdt="http://www.medtronic.com/20220823" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medtronic.com/20220823">
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20220823_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20220823_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20220823_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medtronic.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mdt_SeniorNotes2020Due2025Member" abstract="true" name="SeniorNotes2020Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2040Member" abstract="true" name="SeniorNotes2020Due2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2050Member" abstract="true" name="SeniorNotes2020Due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20392.250PercentMember" abstract="true" name="SeniorNotes2019Due20392.250PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2023Member" abstract="true" name="SeniorNotes2020Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20391.50PercentMember" abstract="true" name="SeniorNotes2019Due20391.50PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20230.375PercentMember" abstract="true" name="SeniorNotes2019Due20230.375PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2022Member" abstract="true" name="SeniorNotes2019Due2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2032Member" abstract="true" name="SeniorNotes2020Due2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20311.00PercentMember" abstract="true" name="SeniorNotes2019Due20311.00PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2028Member" abstract="true" name="SeniorNotes2020Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20311.625PercentMember" abstract="true" name="SeniorNotes2019Due20311.625PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2049Member" abstract="true" name="SeniorNotes2019Due2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2025Member" abstract="true" name="SeniorNotes2019Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2027Member" abstract="true" name="SeniorNotes2019Due2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mdt-20220823_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1aef31ae-1e30-471a-b48d-f5bf090cf9ba,g:b8c4eebd-78e5-4b47-94dd-98c1c8adc6f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Cover" xlink:type="simple" xlink:href="mdt-20220823.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/Cover" xlink:type="extended" id="i42de180ed645419f9027753188241606_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d6ea2f49-e1f4-4614-a369-96bc3dd2f86d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_DocumentType_d6ea2f49-e1f4-4614-a369-96bc3dd2f86d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_26bb12ba-092a-41be-84b6-013a0975ad41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_DocumentPeriodEndDate_26bb12ba-092a-41be-84b6-013a0975ad41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_924bc0a4-139d-44da-9f58-4fe32b547657" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_924bc0a4-139d-44da-9f58-4fe32b547657" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_00d527a0-5adf-4810-a778-f607981215dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityFileNumber_00d527a0-5adf-4810-a778-f607981215dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ff6a53e1-4632-4d44-a114-cc5490f88bf2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityTaxIdentificationNumber_ff6a53e1-4632-4d44-a114-cc5490f88bf2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_029fb320-4d41-4d1a-9ca9-07979190484a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressAddressLine1_029fb320-4d41-4d1a-9ca9-07979190484a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a2651d0d-dd22-440e-952e-db0aaa275831" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressCityOrTown_a2651d0d-dd22-440e-952e-db0aaa275831" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_5f89def1-8386-4c44-8318-c0c60bcb1cbd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressCountry_5f89def1-8386-4c44-8318-c0c60bcb1cbd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_b5dd2e75-5c82-4a86-9f21-be7f7787e9e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_CountryRegion_b5dd2e75-5c82-4a86-9f21-be7f7787e9e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c106d95d-88f7-481b-bae9-cd1491e304a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_CityAreaCode_c106d95d-88f7-481b-bae9-cd1491e304a7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b048c882-3af2-4763-9380-93e73ce4039a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_LocalPhoneNumber_b048c882-3af2-4763-9380-93e73ce4039a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_53bc752c-0032-4e30-a882-4af45aa4ad37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_WrittenCommunications_53bc752c-0032-4e30-a882-4af45aa4ad37" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b5c10f6a-e493-48d0-9bec-b2776c2e29a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_SolicitingMaterial_b5c10f6a-e493-48d0-9bec-b2776c2e29a2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9745841b-ea11-4408-85f1-5b29870f7ace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_PreCommencementTenderOffer_9745841b-ea11-4408-85f1-5b29870f7ace" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_279a57f0-c9fb-4b99-a873-40a6bad31b1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_279a57f0-c9fb-4b99-a873-40a6bad31b1a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9add49d9-57a8-49d4-89f5-82fd56c23fa0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_Security12bTitle_9add49d9-57a8-49d4-89f5-82fd56c23fa0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c2ebc358-0fbc-442a-a00b-776ee5ca3ba1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_TradingSymbol_c2ebc358-0fbc-442a-a00b-776ee5ca3ba1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_116e9a5f-8ff9-4ebb-8985-a5cfc4993115" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_SecurityExchangeName_116e9a5f-8ff9-4ebb-8985-a5cfc4993115" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0f999795-7ec3-4bcb-9a15-78a1509f0f12" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityEmergingGrowthCompany_0f999795-7ec3-4bcb-9a15-78a1509f0f12" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_59933eea-de7a-41d2-8295-4b8175f16eb5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityCentralIndexKey_59933eea-de7a-41d2-8295-4b8175f16eb5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_28bab2a3-2435-463c-b108-c2381d8ff45d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityRegistrantName_28bab2a3-2435-463c-b108-c2381d8ff45d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4f695fa1-136a-4c7b-bfb6-910fb870d484" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressPostalZipCode_4f695fa1-136a-4c7b-bfb6-910fb870d484" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_233027ca-0a1a-4a0d-a987-5f3c797e3b18" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_AmendmentFlag_233027ca-0a1a-4a0d-a987-5f3c797e3b18" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:to="loc_us-gaap_ClassOfStockDomain_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:to="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_46689b23-3d71-46d8-a890-f305a300f1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_us-gaap_CommonStockMember_46689b23-3d71-46d8-a890-f305a300f1b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member_2990bbe7-b404-4469-912e-0bfc5ec1d792" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2022Member_2990bbe7-b404-4469-912e-0bfc5ec1d792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember_7f784b64-62bc-4d32-83db-3c93f07e6978" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20230.375PercentMember_7f784b64-62bc-4d32-83db-3c93f07e6978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member_add4beff-5f45-4882-9365-6739119dcb4c" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2023Member_add4beff-5f45-4882-9365-6739119dcb4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member_be7d2bb5-ee9d-4f46-bc24-bba46fc21c5a" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2025Member_be7d2bb5-ee9d-4f46-bc24-bba46fc21c5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member_dec8cb76-5346-4b53-964c-8722d5944db3" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2025Member_dec8cb76-5346-4b53-964c-8722d5944db3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member_cf6d2912-52c0-46d5-8a99-50de779492e4" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2027Member_cf6d2912-52c0-46d5-8a99-50de779492e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member_21c7c247-0c4d-437f-92f4-60f19902d63a" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2028Member_21c7c247-0c4d-437f-92f4-60f19902d63a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember_eaabb95b-9d95-4c87-aead-4dbc49cdcbde" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20311.625PercentMember_eaabb95b-9d95-4c87-aead-4dbc49cdcbde" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember_53389265-b995-4880-9aa8-4d93db661949" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20311.00PercentMember_53389265-b995-4880-9aa8-4d93db661949" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member_bd572b60-584e-4818-b605-5202bdcb0353" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2032Member_bd572b60-584e-4818-b605-5202bdcb0353" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c95142d0-c3ea-4149-ab4b-ac2a6bf1d121" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c95142d0-c3ea-4149-ab4b-ac2a6bf1d121" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bb0de89e-dc67-4903-ac9d-7be020c506d0" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bb0de89e-dc67-4903-ac9d-7be020c506d0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member_8c32e40b-48f4-49d1-bb8c-57f074b91e27" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2040Member_8c32e40b-48f4-49d1-bb8c-57f074b91e27" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member_f74917ae-9f7c-418c-a996-62a10537fb20" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2049Member_f74917ae-9f7c-418c-a996-62a10537fb20" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member_73bf54e5-8f5f-4143-af3b-9a37f291f741" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2050Member_73bf54e5-8f5f-4143-af3b-9a37f291f741" xlink:type="arc" order="15"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mdt-20220823_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1aef31ae-1e30-471a-b48d-f5bf090cf9ba,g:b8c4eebd-78e5-4b47-94dd-98c1c8adc6f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_e83a729a-9080-4e94-861a-104565259a45_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_e14d0045-2aac-42bc-8128-80c113d4c100_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2025Member" xlink:to="lab_mdt_SeniorNotes2020Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1fc556a5-47cb-49b2-a5c4-f237aeba497f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6070a31f-ea1d-4ce7-b9c7-d007bff94279_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ee5a59b9-32ee-4a76-9a30-facb5f3d4f6f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_fde80cc5-dc69-4385-a958-783484ff127c_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.375% Senior Notes due 2040</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2040 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2040Member" xlink:to="lab_mdt_SeniorNotes2020Due2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_036736ae-80be-40cb-9978-2e9a7d16cdbf_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Senior Notes due 2039</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 1.50 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 1.50 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a1398d13-4e3d-4ff0-8a89-64a3ce8f3702_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bac57b03-4865-45c9-8094-b58b36b9ebf8_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_e4ec6fd9-df67-48cf-8369-7e19c35d2ad4_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375% Senior Notes due 2023</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.375 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.375 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c753f78b-5f9e-487e-8a25-b121cb394d42_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_bb381902-262c-4b77-a5fb-302eb34cc239_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_f85bd543-f2b9-4ab1-8ace-fb8be508cfb6_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% Senior Notes due 2049</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2049 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2049Member" xlink:to="lab_mdt_SeniorNotes2019Due2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_76803ea7-b65b-4ed0-b96e-fb93acfaf1f1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_83aac7e7-13d0-4dc7-8eeb-bf3bb170c147_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_51881408-c3f5-46a2-a4a9-a8a7bd69fbb5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_8d635543-11a5-4bde-872e-2b118c661aa0_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Senior Notes due 2050</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2050 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2050Member" xlink:to="lab_mdt_SeniorNotes2020Due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a5c00467-68a8-4794-bd02-5658d9f35c1e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_a1b080b5-428a-4403-a4fa-849b63600bfd_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5a3eee66-17ac-4efb-a482-b66e236dc28b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5e8d44e0-a08f-4ecc-a55e-452009a8d689_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6ddd29fb-b2f9-4485-a43f-e962571c8f02_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_a2510dd3-16c8-4145-9f91-fffd7d1f3221_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375% Senior Notes due 2028</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2028 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2028Member" xlink:to="lab_mdt_SeniorNotes2020Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_748ed9b4-9375-4a71-be95-e0f80ef107b1_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Senior Notes due 2023</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2023 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2023Member" xlink:to="lab_mdt_SeniorNotes2020Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9ca3ab26-f6bd-488e-be04-db87d7ad68d5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c2c5f8da-4b87-4942-8d8e-cbbda70d2d93_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value $0.0001 per share</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_017723f5-9603-4f6e-9e3f-0cc8ee0991a4_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_a124502b-b4f7-4199-ad83-b76fccac6be0_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.25% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2025Member" xlink:to="lab_mdt_SeniorNotes2019Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_715a5d15-ee94-4bb9-884f-197bc5570322_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_87007462-6485-4a25-97c1-2ef825ccf1e4_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.00% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.00 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.00 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_95952245-e6d5-4818-8f66-e0f1fcdd7911_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_98cce252-6ae7-49a4-b2c0-e03ec5e0a5bb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_b4ab3240-66c3-4694-9d44-3265df270876_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_4cdebc20-b5a2-42c4-9d24-0c597411bc38_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b16557be-bd2f-41e6-94ac-194cb668562c_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_34386da3-ce57-4a3a-b570-6ea1ca458185_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750% Senior Notes due 2032</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2032 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2032Member" xlink:to="lab_mdt_SeniorNotes2020Due2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8fec9816-9808-450a-9107-58c763bb72a0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_51195ce6-a1ed-4789-94f6-a19fa7a0a228_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Senior Notes due 2039</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 2.250 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 2.250 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c3a39873-9276-4723-bcf6-d566326d21f4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_3b77e979-6462-40a4-bb03-34b71a74785a_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.00% Senior Notes due 2022</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2022 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2022Member" xlink:to="lab_mdt_SeniorNotes2019Due2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0fed9f5a-ae5f-4a35-9e75-275363f8b39b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f2273747-09f9-414b-9d04-c47c34e297a5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_52139dd7-4e98-4ec5-a56e-75181482d853_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_28cb0df9-2913-402f-9c6d-56839b597e24_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Senior Notes due 2027</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2027 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2027Member" xlink:to="lab_mdt_SeniorNotes2019Due2027Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mdt-20220823_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1aef31ae-1e30-471a-b48d-f5bf090cf9ba,g:b8c4eebd-78e5-4b47-94dd-98c1c8adc6f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medtronic.com/role/Cover" xlink:type="simple" xlink:href="mdt-20220823.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ce90a800-6bfb-4ddd-9ea6-05cffab8630a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce90a800-6bfb-4ddd-9ea6-05cffab8630a" xlink:to="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d3b34ed6-61f2-4efc-b9bc-2c7a840380a7" xlink:to="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_46689b23-3d71-46d8-a890-f305a300f1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_us-gaap_CommonStockMember_46689b23-3d71-46d8-a890-f305a300f1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member_2990bbe7-b404-4469-912e-0bfc5ec1d792" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2022Member_2990bbe7-b404-4469-912e-0bfc5ec1d792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember_7f784b64-62bc-4d32-83db-3c93f07e6978" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20230.375PercentMember_7f784b64-62bc-4d32-83db-3c93f07e6978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member_add4beff-5f45-4882-9365-6739119dcb4c" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2023Member_add4beff-5f45-4882-9365-6739119dcb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member_be7d2bb5-ee9d-4f46-bc24-bba46fc21c5a" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2025Member_be7d2bb5-ee9d-4f46-bc24-bba46fc21c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member_dec8cb76-5346-4b53-964c-8722d5944db3" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2025Member_dec8cb76-5346-4b53-964c-8722d5944db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member_cf6d2912-52c0-46d5-8a99-50de779492e4" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2027Member_cf6d2912-52c0-46d5-8a99-50de779492e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member_21c7c247-0c4d-437f-92f4-60f19902d63a" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2028Member_21c7c247-0c4d-437f-92f4-60f19902d63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember_eaabb95b-9d95-4c87-aead-4dbc49cdcbde" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20311.625PercentMember_eaabb95b-9d95-4c87-aead-4dbc49cdcbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember_53389265-b995-4880-9aa8-4d93db661949" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20311.00PercentMember_53389265-b995-4880-9aa8-4d93db661949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member_bd572b60-584e-4818-b605-5202bdcb0353" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2032Member_bd572b60-584e-4818-b605-5202bdcb0353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c95142d0-c3ea-4149-ab4b-ac2a6bf1d121" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c95142d0-c3ea-4149-ab4b-ac2a6bf1d121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bb0de89e-dc67-4903-ac9d-7be020c506d0" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bb0de89e-dc67-4903-ac9d-7be020c506d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member_8c32e40b-48f4-49d1-bb8c-57f074b91e27" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2040Member_8c32e40b-48f4-49d1-bb8c-57f074b91e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member_f74917ae-9f7c-418c-a996-62a10537fb20" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2019Due2049Member_f74917ae-9f7c-418c-a996-62a10537fb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member_73bf54e5-8f5f-4143-af3b-9a37f291f741" xlink:href="mdt-20220823.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ee6e21c0-7315-4c90-861a-254097dc01a7" xlink:to="loc_mdt_SeniorNotes2020Due2050Member_73bf54e5-8f5f-4143-af3b-9a37f291f741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_dcc4452b-d46d-4254-8caa-cec0b7c3c866" xlink:to="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d6ea2f49-e1f4-4614-a369-96bc3dd2f86d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_DocumentType_d6ea2f49-e1f4-4614-a369-96bc3dd2f86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_26bb12ba-092a-41be-84b6-013a0975ad41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_DocumentPeriodEndDate_26bb12ba-092a-41be-84b6-013a0975ad41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_924bc0a4-139d-44da-9f58-4fe32b547657" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_924bc0a4-139d-44da-9f58-4fe32b547657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_00d527a0-5adf-4810-a778-f607981215dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityFileNumber_00d527a0-5adf-4810-a778-f607981215dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ff6a53e1-4632-4d44-a114-cc5490f88bf2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityTaxIdentificationNumber_ff6a53e1-4632-4d44-a114-cc5490f88bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_029fb320-4d41-4d1a-9ca9-07979190484a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressAddressLine1_029fb320-4d41-4d1a-9ca9-07979190484a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a2651d0d-dd22-440e-952e-db0aaa275831" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressCityOrTown_a2651d0d-dd22-440e-952e-db0aaa275831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_5f89def1-8386-4c44-8318-c0c60bcb1cbd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressCountry_5f89def1-8386-4c44-8318-c0c60bcb1cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_b5dd2e75-5c82-4a86-9f21-be7f7787e9e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_CountryRegion_b5dd2e75-5c82-4a86-9f21-be7f7787e9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c106d95d-88f7-481b-bae9-cd1491e304a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_CityAreaCode_c106d95d-88f7-481b-bae9-cd1491e304a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b048c882-3af2-4763-9380-93e73ce4039a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_LocalPhoneNumber_b048c882-3af2-4763-9380-93e73ce4039a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_53bc752c-0032-4e30-a882-4af45aa4ad37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_WrittenCommunications_53bc752c-0032-4e30-a882-4af45aa4ad37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b5c10f6a-e493-48d0-9bec-b2776c2e29a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_SolicitingMaterial_b5c10f6a-e493-48d0-9bec-b2776c2e29a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9745841b-ea11-4408-85f1-5b29870f7ace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_PreCommencementTenderOffer_9745841b-ea11-4408-85f1-5b29870f7ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_279a57f0-c9fb-4b99-a873-40a6bad31b1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_279a57f0-c9fb-4b99-a873-40a6bad31b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9add49d9-57a8-49d4-89f5-82fd56c23fa0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_Security12bTitle_9add49d9-57a8-49d4-89f5-82fd56c23fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c2ebc358-0fbc-442a-a00b-776ee5ca3ba1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_TradingSymbol_c2ebc358-0fbc-442a-a00b-776ee5ca3ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_116e9a5f-8ff9-4ebb-8985-a5cfc4993115" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_SecurityExchangeName_116e9a5f-8ff9-4ebb-8985-a5cfc4993115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0f999795-7ec3-4bcb-9a15-78a1509f0f12" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityEmergingGrowthCompany_0f999795-7ec3-4bcb-9a15-78a1509f0f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_59933eea-de7a-41d2-8295-4b8175f16eb5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityCentralIndexKey_59933eea-de7a-41d2-8295-4b8175f16eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_28bab2a3-2435-463c-b108-c2381d8ff45d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityRegistrantName_28bab2a3-2435-463c-b108-c2381d8ff45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4f695fa1-136a-4c7b-bfb6-910fb870d484" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_EntityAddressPostalZipCode_4f695fa1-136a-4c7b-bfb6-910fb870d484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_233027ca-0a1a-4a0d-a987-5f3c797e3b18" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_73209ac1-8952-491e-82ee-31590e13d64d" xlink:to="loc_dei_AmendmentFlag_233027ca-0a1a-4a0d-a987-5f3c797e3b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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M9QS/"Y8.8C,G-M61YG:?^+H\R\<1]4>AM4[P""DM==*FT@'\_HZ&7ZQ/S>?
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M0K9-LVBQCRRDE<L/T>U;CZ3HA.F!)!?C6F!O03.V1L403O!L1X<P[<BU$P/
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M^#/8:(W[A/>E;K5P[EB#]8>&@"6U6K'NP. $@P5=>9ARI8[)ROSN_[T78+E
MIPM:5S!QPQ@LFE0[Q=X%PS"\QP (,@-.92;T/0V)[^U;C^GHX:NB^#K >PQ
MFQ8-1W## #(&>7/8"NOM<Y>67$.W$,U(%-36+*QP7W'N8 \&L[Q&I6 &TF4#
MK7A^T.A%X?(@$R/[MA)9%VC]E&63UV .B3,*C/[:56!@%T&M&H_D/*)KA]$\
MR@SVL8?S)/)RF\+-0ZQE_P$S>;S=VWTJ&R Y]Q['H^Y@YD,COD6C*&I49SCU
MZS&>&? KEAQ@>://!0I;@&5XQR%!!" 7[[9U1YNU!J4& +ESLQS[8?>."3PU
M!/8A/B^84F"FHC!'L\F<>R+>5;UQ>_?WIYS#0G8 YU-4Y#*6XX'1:BWHOQ?T
MX6D(Z^Z%&ANZ@ $4P=F!]^3TR9O,4+1$9 V@57OG,!V"!@(:3="'C!FQDI8N
MVL]Y  !U-'TLD6_HYRF IZM7[O/4"$:I 32"%8AWOYAX7M;4A=>]'J!/FQ2_
M5GS&LQ9K=ML[T(JU@+WE_+G;#&H#M$1]@ D"Z[-9]6D*L??^Z,*&;M4KA#![
MM&^/9&Y,C$U8S^\-UC&:\9 LPS[PM=K3U'N%:3Z MWA/<=_V[;U :U8>Y@D&
M2(ZAKD*3H&VS&*HOUA1,MXL7\#'X4?0SR(2X4JW*80IH5:'"CL(DH/7-ZW<\
M=@"M*;!UP&C &+D4H%4<5E7+!C&K !U^=&J_%@"2L$'NW'Z6?$6AH#$O7"1H
M?VG_/EB?<.-VZJ5I@Z+3C"ZU.>)_!G88F .0<$ Q@,/)LFPO@PG$SVY4K4(P
MM6\5PV+\O__^Y*O@% XJL%KFS]Y%'=O$4NX<XEE^+[=["@8M1J< >J!P 6AD
MK@"8")!U_=ICS%+$6 F8DM9A*6H@/T#6IO4CJ;_+% 8W=HCW%>QGR +@>0 P
M^V!!/2P]M(3E7X/DR!ON% -P/7+X"H.-8 >AJP[A^9SI  $Y]\J9QZ;0G89&
M&KKDF66Z928PK@SSK<$!\SB)S/>3NT3 Z^MK!OK7&-V%KC02R3V[SO.[ E ,
M">W?AH36TH9A[UD'_!TS%,"&1L&.D2X8Y<"T 5("T$?DO=PF6!CI+PUHK5=C
M" /X\V;OM#+0JIT5*#3!'*Q1T3I *S3$,7T!&1T%M,I_O_6]53.U\V>M>XS
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MTF NM,&,P?C UP+%)8H",.AB15(!!T%HCLE**+0BQXW-N^#0?>/: RY.S)%
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M[\@U#),'6L10>,@"GOXS9]@CT(J\".^=G_<,:E(OT@"TRI>LPMY30*PGW .
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MO['GF:4#>R T\@%R(&<!T !S)$R!R'PG=8WJ2J4#N>!?L?0 %_RV*+-@K@!
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M/,8W8T>L8/=DN!C+!\04T)K^G5) J_GN)>0P4,"V:C*2)HW;Q)_+6'D32P?
M/I@?(6<)]I]+91Q\J7 >6>!-ZCT#R% HEP?5JQY.B7%KN4'YZ-&?-BFS8*[
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M5,OJ\>K56Y[8@M:YK^=T<LCO)8G,H:\3)UXGF-8# ]Z<#1%[ EIA]HOW;'#
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M"6C][?P='A^'WE:=JN$2@59M X>[YV)Q6((=F=G1>P3 AO/G[G#!UZ3>,$D
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M4(4*%?8=)@&M8 @-#5THBO@15*Z8#+#)8 ;TDPL5RN5.OI[3:<^NWYA9:8I
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MS*2M77DPZ\0>.G Y0\T&@'O3)F\1:SR:C;OR_R07:"V6WYL;,F!?@[F=G0K
MS 0:<7C'47R@00>#,$UV0@&M"FC-?%@7:'6C^F(]N?2>P(PE,+5M.1X_?L'
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M,YI-#8SIGSM[BTVE^G9/)CD&0>F2GN_ZB7L^A)+'K*>SXK/ '5D!K>KZ[V4
M6@OY4.TJ@REXT%PZ?. R U9?8M)_7J/5.M(!T&@-#;)SC5;Q+- @0H&%O2Q5
MHU4!K0IHS7PHH#7CD2H=8'U&*QJ[YY5&*P>D [!V4M:?(!<K2P<HH-5V0P&M
MYKOL!VC5"%&UJPZF1%&G0T++7(0H%2I4J,A*8130BC%V@%)+%NZCSNWBJ(@H
M6/-* )MP2.7-X<KF6\T:1#! !I%M;-[FV+\!_ITX=HU9HTZ]QK-#N)R$0DLX
MZU0-HT$^L_CG_W;NSB>?#2/(.\7!&1>]FIK5'VY@@%I6IB'/CY!I\*%:5;3#
M$I_AW;L/9I%I^//Y*Y'LW*&5RPZ28\]Q9 V@%5?]FN'BNZT1!?]U+@@S#[0J
MZ8#L?VG@4,E" ZANM5 :'#"/CAZZPK(!__LBT*J!6O?N/J4)8S>R1$6E4OYB
M3W'E?4S&9P8H@\_<NFD4!?G-H<VBD+57H!7?&PPNL-DBPA>SKG@198:E@%8C
M0P&M&0];T6A--<.ZI8!6TLRP;K,9UC&#&9:+5<RP&BHS+)L.!;2:[[(G,ZQ2
M1090S<HAE#!J-=VZJ9EAF:-V5*%"A8JL%$8!K=#H!(  0+!#ZUA.-/*P7JB%
MC9G^SXD9897+!%"K)B-I0G(*=\K,U20#@'SE\CTV!_#QF,8&7]!.M31S5$\X
MJY4/(9<^$QB8 >";-B ;L&;E$1H2LI 34\L"K5H"F?\7=ZI2+I#:-H^F:9.W
MTOW[S[E(-T=7\L6+UW3ETCU:N^H()_GRDOM/OV>]ZN$4%[.*3;Y^__U))H'6
M:*71:A>7!@ZA0P\&])"0!:PO_+^O,.GQZU@O !DFC]_$IFO8M_+]))$ESW('
M ZA%HQ'DYS.34L2^9J] *PK?%W^^H5,G;[ Q&'3%"^?V4$"K EJ-"@6T9CPP
MC7/JQ T:E[2!Y9&L [0Z4;>.":P)CST &O'V'B_^?,W )N2R^O5(9E-6R^^'
MZ9^+,S6L/8RBAZ^@'5O/\H1:9D,!K98-!;2:[Y()M.[9=9YB1JR@[IT2J6RQ
M05*!UMPY7#BOJ%H^D+U4\'Y"(_^?+W@:J%"A0D5V#:. 5@!-=VYIQE'MFD=1
M@5]<&9"4 ;2"95JM7#"U;QE#4R9L9NT7<\6[M^_IP1_/Z.CA*\Q:@R0"#*=0
MW%B^&'>F"B4#V"%R9,0R.K#OXB>?#>-N2#1\/6=0[2IA%DX,M(*N4.[^U*#F
M$'+L-8X6+=C+NF;F K5?OGQ#U\7ANW'=<7+M-\$ 9LLLP+2?5[=:&"<CT)_5
MV=%?BK1 ZP(%M-K1Y<2-C7+%_)B1%1F^F$X>O_[--8[U GU"F*V!_5RU7!#E
M_\E=*M!:O( /-:T?23[]IS%SZ4,V*@ S$V#B@\5V5!1J(6)OAZYXP9SN"FA5
M0*M1H8#6C,?#!W_R_8(6.IZ[Y1O7G]L+G9G9-6/J-CIV].I_S$;M,9X_?T67
M+]ZC98L/4.^N2;P7RGTVVE[0J,XP&A6UBO;L/,\Y6&9# :V6#06TFN^2![3^
M2_OV7*#1L:O%.Y$D?IYDH/4'%Y[VJU1Z$->S%R_<Y>=FKXU^%2I4V&\8!;3"
MF DF5#.G;:/63492OD]&CBQXZ )H_<E-%#8AU+EM'+,LP:PU5VBLI]=T21Q\
MT<.7445Q2&"\5 J(;-!3;-Y@N#C\9W/"IFG/:L ?&*[0>@3H6;5\L!2@M6@^
M;P83@_WGTOJUQ_C>F"O 'KYUXR%M3CE)'LZ3>/WD^EXFV*HE^9!KP-@:'#IO
M7'_X3: 58#P8W7 O[M@ZEDH6\J'\/^M&< ILS8Y73@/06J&$/[5J,H*B(I?1
MZ9,W,[3.P>9"<0]#*NQ;^7^6"[0ZB'>X0:TA7"2!$?_^O>GZREDQ8(0%P <-
M+'_?66)?]Q#/PE72M(("6M.N2P6TFO!.9T&@%>Q1%-K(US"))!O0T_?OCJWC
M:,+8%&ZJH@%F[_'TR5^LNX_I'+#><GUG#:#5D9K4BZ#$N+5T</\EHX@3"FBU
M;"B@U9Q[D1R@%<S10P<NL0%AOY[C1.X:(!5H13X!?X_210?0T-"%XKR\R?6C
MO>:?*E2HL-\P"FB%$1;&OJ=-VD(M&@TWC!S),8P"4%&[<JA(#!-HYM3M9@5:
M483^_>X])WL -:'?B03*\KJ*6O'ID,^+:E4>S D-F)[L:OZO-FJ!)'1$Q#+J
MU":.*I3TM_"AJ24X&#M&-S0Q;@WMWGF.P5%S!?02(?NP?>L9\G*;0GE_<M;
M>FG,5@V(JB76TK#0Q:P/=NW*_6\"K3 "@XD$3+RZM(OC]5$@ISM92V-679:_
M]$*]4ND 9M)C% I 2T8"X-[L&3NH6\=XJETEE K\["$5:"V:QY-_;M\>8[D0
M_?O=![MT?D5QAK,"NF4#^D_C*0R<6PIH54"K,:& UHP'M.\QHCY'[(-HW.:6
M/**>T_ .MFT>0PFQ:SCG,.<D5%8-F+^B@8\\&FQ?G'%R],,_O2 G@7P;<CS&
M . *:+5L**#5G'N1/*#UZ.&K//7IUF\252P5*!EH=1(YEINH:?M3B/]<GB(
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M=HBG1)&WGCYUT]JWQ>J!*:79,\4:]IC&^Y-LH#7?SZY4-%]_ZM5U#$\(03;
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M=]EH5A+Z=IHF4J)P)ZE5=8 $U1^IZUSMXWZ2\^WF7@:U+8U6!IQU[31/OSN
MHC?, K/_5(!PZ, 54J98E+R3K:6D?=TI$"1&IJ%FY0$J18%,0EP!-*:8,ZAL
M4+]E\F&9[N)= #[FX?VD21&JVL@ 1V-'K=7"Q^/'/\ICDW \<A^O/78"%1^
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MQ8+FH0C V<Z<-DR:AD[088:PU9E,FQS-\B\BAP]=5 W D*]&2Y%\[5V@U6^
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M8"=_6JFO%,W?7M*_V<BY(,[\G.P9FJE(?-/0\3J-/:Y *TD9%5D2!8 <DC;
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M1"H( X!H#_[QIJ'/ATQ!K6H#I/B['23]6XT<6N.8_83^;4.3M*Y8>B#.0"O
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MJ[K#I4RQ*"OI<A!HS1P0)L4+=I#Z=8;)(A.H$Y3$AUU!Z\N*I5]+U\BYFL
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M0+-G;I>:5?IKNRW5)T> UA1!DB%EJ+R;M[6VBC*D("& 6$*- !'VP/Z]9TW
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M[CUZ^)+J-R666;ISO\F=VX]U&C859X;_4$%GTFC::&9K4M@_R?OQ-=#*.21
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M0UFW^K#TZ[58]07S9HOP<__M/:#5'MH'6,+=RL3ATD4[NT#KOY@+M#IK[%$
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M;@-_69N$[1D7:$T^A@0(4DZK5QS4V 8R %K6!7*U5G:[53AQF5;_M*_L3@#
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M+=[%0RSRUZ&0S@*M]CIIKO)K3*ZR;/%^+<S4J#) ST,F$X^E^K\0%VR-?F*
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M;\+WD.U+B!LH.+Z;N[5\5FV@=&HW2\&L_<:O4(0'/ %P\E<FJVTNT.I=>]6
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M]]SVI'O4)[8LLR'H*"@4' B^N_AW=>_MO5+S_7QOVZL\-,""8!R^=4E[>T(
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MO#_F'%VOY2Q^;VPK/1!M:!#@NR'$XR^)!Q@;++?E1&FZTH=ZVT/'U(X*,_&
MHBBT$O/3W91:\>,OXL"S?0X1]E7N:<58FAGPOQQ.0\Q&[($]3X\O&</\/PK)
MW \%18KZ'%R)3:4A(';OTT1#GD",/<+[_7E)%W:F7:W\?<8#V[21,_!,Z:8\
MW8]E?G<4;\C#F*-\!\1%XA#++7WLC\_@/KB?N%*.BVVF:'Q *'G>_PRVD]B5
M?)5M@[!E-'CDB'GA?HEK$:DYR!G_3I[)LO/=73T9A58$/&QR%%JQJ?QNBK2W
MWO"$'8I&@P\B5B@&AYP(GT6\1JZ$R,9GD#^QARH%<7((YAWWQQ@G+IG)=_Y]
MQ0YSM[C?,GZ%6(:B*LO;R<_XG;%XQ_- N&>5%IW\"-8-ZX1#*QG//!]\"+Z%
M,15S7MY#S.WY?HAJQ%7$5\2";%='SDM'+^^ ^(C<::#/CYG+S&L$Z/)6N"YD
MH=7[YSOR$EIO[6[?<W>$5CX;X0_[0IX0?:;I)?[9(;J93R9N\O? 7JSE[5R1
MNK;="D5F*_CZ.4@>A*UE17&ZED!,PA@W'^-M!]^5N4Z,16Y+82<5!QT:5MR2
M+U%(Y1VP'1,^8W<*!_S\RN0@8&)B"C@TQ1Q3JK:)K.7^&_:PI["'-D*,@F^E
M $E^Q:H1YBA[RJ?;(;LG/T?92@:!G;@;N\]>K[Q_YN*1B3@?FI2J6*$)T98#
M '_P>5!>JR;R _>#'1OI\RV:L,*VD$%H924F>Z,^?&\OFV\(W'37Q]6VV'M6
MKM!%SP&0Y*/,">81<Q&=AV>.?D&<RO8$; >"[H _32<6TUAUAY!ZWYT]+;<D
M-XE;I?!]:%PA-V,U!3\?_'B!;WN'Q-43=&</'_J)Y;S$1F6+9:?T&\83MI-8
MGM7!N[,R.$.A-:C/Y9-."2J8.$4,)P]_SUYOF]'%"&,("?IIL2[('ATFM-H2
MAI=-^ I":Q#BZ&*AFG:W#\CIX#KCY+#D%Z=/JS1!!DL@$7LP/G3Z\7D(<#AG
MN@FX^'><+$Z,"CCB <\5<88 ]8P3&R4#/W2VVI(X_])IJ6?/L->](<)19 K.
MB" 70\3O)C"F2EZ^1.S4"Q,<I\B]$URQM&/8D$_=9SYHHW*( >+DX:7)/2ZW
M>UQK_^00'>Z=9T U8];,7ZQR2>#4HLEP6QI E9+[(U@[IG0=,\0$-1B B\YJ
MZ4ZDLE]L_Q!:V0?U-?_9&$.$Y"BT\MET(% IPJE<>?&C]M^V781/%!&P"?1X
M!XP# APZ/7AN2_,8.W3.$DQ@+*D&8:PQB%1A"-32*_,D'1A)QC+!"$M("'XR
MA6"%\<WGT1&%82*YX2"8XLE^OOQNZ\;VSI0. @);'"<;<;.DP\:-3X#"_:T-
M]\>X\7_&OI(8/O8#HXL;,8JNU\K>N-.U$(7.XE;%K&ZVB*52"%>,S[A,(1.#
MS+84B*P?^N],H$J5E'G [XZ!>+FD2,#<P5$RMG&D%'IXSKPGQL6R/.YQB;]'
MG@,=#=@J'#*=@XP13N6EN!$%Y3)),0>[2Q64Y?QT]FRC.V4WMA!@GSRZ*2D*
M$<@1=$7AXKR*S=T]M_>PKK"S3VV2$E<81W3-D=Q2;2:P11PC6< .,,=Y9]P3
M%]\/^\8X#G9XQR?W%J70RC(/QBF=1-B7U+ZI_AUB?[#I=)=>=<EC5O @"*1+
MBH""3AQ\ ?,2@86@(#4OE^?,RV6)36=[#NX9L1\AG>=$HD"EMM3A55)!#1W]
M!/8$+ 3B" Z%41R(AY00T-%I=D5RLCS%P%)))ROO&)N*O\;?T#% $LG2+IXO
MXW9'-CW:G\6)[R*QX7!($FF$Q5M\,HB0PKS@&9YR;"/K;J8#EF<9.H@:6>5_
M7Q-:"9[H1F/O* 3-[[];Z+[QMHH+F\6<GCGC9QM++X^<8 GB*<?%+IU*UH5T
M2A*H=GCL%=L&A^># !,_9_N+SYW]PR+WD\V3E3OT9SL56CDDQ_M%?,KE%[9U
M-UW;R0[*8;[2A8 X1!* :$:0'DX^_M,M]..$=XR?SA6;>-M$ L42-6PO[Q=1
MBSVQK8.Y;([0R5BV+2>.K6>=#XSC!<E!7)G O:Y<L=:>=;<GWK!DF&5M=!DP
M?F-7+=TP/&^"8_:@0\3BH$+F*;:7L<K]Y8Y+UEA<0OS%=V6N8N/[^<2(V((.
M,);:YG2WA>U@V.L2>XD=XC!!;/C^ ,D8>R"2[+ :BX2&$YL1JLJDEBJ&.(_X
MCV2/HA1B 38!/X]M9SDQ]_S7\NUCV=4V=OF9.3_\GCJQFX-02-*B>!([G2CF
M66'=C^$.R=Z C,/\;,G /$#(Y'?1K40WVA7^_7-*==ED:33O"_M#YRSW@FV:
M[\=[0;;<(HG%+Y-4(83@%V*\%L<]VV<1M[$DGVTEN(>M.]FVB#TK27)_7Q1B
MMV_3[< WX6)<,1;YS-MOZN)*'T%!,*>KE#F.J(C(QL]RP$BP+WG;F&^_^<WL
M"_-A:;*MTLY\#/%9X_IL$]3.QGM<I5/FB"K6H8KO9^7*Z2>$+E#B L81 ATG
MF-.]Q!D'4Y/\Y[=?EUHL$.*"91:SXU^X[)WOX-R *+2RW0*Y'*M_.)R+9<EA
MC]*J%C>SM)A<@M@26T$\S-A(S?U4?+EFN]AKE?T<[X&#*7F>8;NXQVU%0N@J
MJQRV1_)CERV@6+$U)ED"F^G65.2D'+[$',-O(J)4*!OBK+B\GV=_DA786UL'
M,"L>*-H3AV"W>*;$R;ECZ+6Y[A$;C\^@L(Y817[,UE[$ZQ1?2\0M/I)N0&+,
M2\YI:P=18><HZ.^N/T9HC0>+;B^T$G_0Q4AW(F.-;CCR,?P5%S8#GV7;.OEW
M@R@ZP_LBQA3Q7/J8XEF0+U'\8K7!AIT<_,MX6_'7NN2,@E>L80"Q'L$L[,<:
M\\PJ5B2ZZ^9N%D<1UU/PXYT1U\:\?ED>\=%2RWE7VO>D8YOB%B(=#2;X4&R?
M'696O);%1XBM_#G%2AHY$ ]Y/G'OX7U9:&6,,><0RA#$XOOE.2(6HI-8?.US
M"58[,)YYUK:2Q\?YO%^>#;$?194X;W/%G3$F27P,VX?AYQ'S$*9#XTNRXB9Y
M?\Q9QC@=I<0\8<N4W=OV@R7NC+=7?,R'_2-N1BRGDY]"#/$KY[*0)R 4\ZRQ
M[3_]^.>.[="R),]=O-(..N?G&9.#!HP/7<T^GT3<RSGCH;*MK+GP[)8^7QAB
MA[;2:5N0PY@B-%KA#UCY=,_MW4,Q[Y 0SZ%GD?-==D$;:XI@M25; '+N!DOG
MR;U9\=BUTYL^!I[HO_,/%B<36\2\CV>-G2<_X)^\._*2O%:Y\S[B ?2(F#0W
MEDFV"T%7Q,?0P<_\H/F*^)C/*<SM6[#%?";/!+$??8:YGR[XXFO8OF[H<Q_9
M>-^=WU\(0FO84[2"3\CI5K%E#3Z!(PC9LU<?4]D9J%14J2*L6K6N0.HS Y^.
M!P) 3E_-$5HK686+[B0JRK12$^0C+E'AN/^.)VU9"L^')=H$5+N:!'PG._W5
M.P9$2ZIC+,NB,X.$[<B2V6F&JXIUS-*=1!46![B[)V'&?<\P "S)HZN#R7-\
MLH]/K*"4L];P>K;T"/&':B*)%(D)CH;OG=^*"F(0G588?9S^JR\'$8+?RSZ5
M)Q_3P#;*I_L1,><"[VQPS'3WLHEX$%HK[]M"JS<HB$\(;@0)Y4O42(T=JFYL
M"9"SM*ZRS1>Z1ZB2\4[C/G=L#;'9)P6[&K($[JM7;3 !&Y$.P9/ @?=8WL3I
M.':RW'D56UJW+(D6W7.[NU>K&:5-6VWL4'&DH(*3P>'$H"W8@CH^V6^6G. Z
MPI:;$2#B*#&Z^?G5_R2;U?,\. 2%RC'[!U/51T"BVA6Z#T+00 6<Y\[)YR1[
M.+."OL-XCP27OWN'0?=.3_]N$/Z9CW%9!_.$+1M(P$CFTD^'#.-RXTX[1])_
MEYVXZIT? 02_C\XPEB81?"/LQLYR$@P288(7.C?82'R)GT^[TUF%L-L_E]":
ME9IC+ =!5&9)'?=L2P$K-+#OP\$Z)($$OB1PC .><5[58NX-.Q,W;]_9LRAJ
MH96$F6#2/CN9[S8'+;!H:J<@DU@BB(9]N%K8MC!T:)'<L&<SXVE7G7HQ023@
M)RC&E_"N6$IC F/2G<_O1K#G=]_L U3>!<'*SI*$G1&[O1A[V'02*H+VXVP;
MCQ"TVU+H(T('.-T[C+&>7=ZVY:S8!.Z/SK+\_G[;YVSU!@NL.-2$SAR"3>P!
MW5\LCR,@M?TR[?3.%M9UR=(J;$3QI!-T7Q%:XZ%W=+)C6]F"A.>1?K'?XSP?
MD$WX_'OK5N6[QQ4$B,=1N*?K95%R.C<^:OO/2;]XYXRKG75\[ZJCE6#YR)+5
MW2G>9U( QOX2NQ SV"&EC8=91PCS/BX?WI58@/U=G1R:A'#?O<N;=G@E[]&6
MMAZ6E1(BZ;8C6<8^4[BEX+"[;$Y6$GSW[:_6(4$W$4M#R\4.@T/"OI\\:V)-
MBGAT8?,=Y_ODAJ5Q^=VZ*LY5$H3//@Y%8(0/NG.PM6$ON$HIX8-8"!M%<DB,
M@"\LZM/(,P71&UM-/,QRU[.\S2%&L$-%#JMB26J,\WB_=+#2Y4S!=]G2-?D2
M*!F?C">$#!)'8A(:#NBJ)!<XS_;#KYGL$YEE6XV0U%$X?>'Y3VQ<YE>X9HY0
M!.7G*<#6S1YDB2F):.P&Y+[HR*3;FNV^B.F8.\2@N_ILQ@Y^C?'4PX]Y[%GH
M9 W)J#TO[Y=9I8-8P[[>+"W=5:QA!Y%M#9_/%@C_M@.;3*1!X*69XJ%[>WE[
M72699Y5-[*>PPQ9;^%_B35:D[<RV8,/X7F';GEVO[J.HTJS14'?=E8_;/4:A
ME;C[E./JF3!6\:3&)OJ&CK\F9E\0HUX<^ID=@(CP%>?@CO9>C7'!CHK$85_>
MO\V.(%QP"CV'=%8\N9G% [QO&C+PS\2^Q);AX,7U^2Y6Q@-.2?01K4<,_\QB
M]TO]/?[//^<<43W+]DNE*Y%59)S-4="5DNF_$Y] GLD>DBQWY_G9'K=)\8KW
MS2I&XEER4+X3W6((R8P-!*AMVW8>3T7BX7=_V7[MBVUK' H/V(';;^H:1+^R
M8;_VN&U(A;)U+([&KN+3L8V[LU45?I2_2T&$W.34XZ/0&KJSB;W8*L.VO_ 7
M.2]+LL^OV,IL1MM6(\W.(MK;EASD17:X4>[[MCC3?S>:#KC7'<6:_!'O&EM#
M'L0*!=OK-SEC(=B-+"L4AT[UWI;3O_;R9,M9$5;)1?)K[\-6)YNM$$5\A4TE
MSR/N0C\YM4)C?[_U3%2F@$FG,;DO6Q.%^"B,O7U9:.7>\!,\3TYISUG.7]D*
MLHAD7,0JV!/&.7NSTI1&ER(%?HK1S(==V<_H8VC:8"QC:RBNLA(E;/]3(Q6+
MA?,"ZMLS1>#F=Y!C[<Z6ENN3/5IYAF'__B>M8>/<TUK:_*1CE_>*-H(N@_\+
M!V?F<[[\XU(V@3B:#E=6%;"]$UVD-$D43_P.<Y5"*;FF'1"U&RN;B7?(-6@6
M0-S/$5HKV8H)MA!#>T%L)._CG=%]33$-;0T;2-<\1;SXWK:W#='.YUP[ME=H
M98P]NG_9PSV>'Q&*/U5M'"'XDB.9;_&VK#!C+N(;Q&]\"&.2L7I,F9HAEDA6
MR"#:4WQF)0VV:'<H!*$U[!U$I9K-<4E8F< D6'ON:FI.F 29 .B.F[M:8DXW
M0T%.(H\"$J(B&Q:'C?8KIYP#P05++LLEASHQD3E8"3&&0#T.A/P&X"$Q_]N,
M "(4%5.6$)!\GQX[6Y, +P@[S:V3AN^XL\-E=@9!#LM4$?58SL/^6]Q'W%<S
M=.I5-S$9<85@@'TIZ- A6#4!*]D',[^5W7!R\#;[>P2(? X50I9HAE-D.]HS
MM<.@O+/E&9>W$W"K) >.5-KGA58"?^8'[?377]'13AJ,\X/OS=A!7"V?"!^V
MAV&5@=992#6+]\\XV)+/?:"B*("1"/M_3;/N.(P"3B9G[(3*.$DI57L<QNX>
MJ!:2X'76Q<@R2I)KED"' \NR<O9?HO/1)VTLGYB85"L)5$B0\NN 4L*'_WF,
M,8$T'38LW::#EX-.Z*"-W0>VS,K?)^(N'0YT8S&?"\J69/DU?[]7M[=MSTH<
M>5C*'RJ,X5"CUE9190GUQ FS+9DE\,!IYM?F1(<4GVL0K6;;=APD+\P_ @@+
MO [)2C9:KV?+(A$%ODH"P()"U]=3>0BM=-"S3!"'CLC*[Z5B3/&'[T,5%-&;
M #IV#^QHKYIXB,D_NQ!984]UM%YU48[0RKS$D3,O><:VAZ"W 8B$;*'"\YGV
MU4]FTU<FITCG5W"(8A&=.Z][F\")\BP]"5U".0D5>X_AV.F:XJ"S/_]<M5M5
M:AM#WN<0+"#$T0&(N%'FB&JI)"H<;E/+1"2JQPAODY.]D[ AF_*9C$?"TI^M
M9H.99]@@; O+%4D.L4/,DW#5MGL]NE2V=0Q%F[XO":T0QZR) 5M# I=^\6Y8
M!3)EREP3E1$UTX565J/<>%4X*95N%\;!]I^Q_16#T9T5(W:U1VM8^9*5"" U
M;3SSSWLHS/J?9Y4.-AL?M7[]SKO+TW\GWS_N]XM=(N%G94N%<K53*TUBIR+^
MC-4<%-5^V,'>B_D!N\)W90DFR_ H9%,PB,LZF3>GQ<[+QUZSXB:_CP0'X9]Y
MD-]]%/])YBKW2/&8CBD2)M[MW;=UMP),G*]<"%T4NEB^B\\.!?7,MTDH*GC'
MV&H.VF%Y.3;(DK=D50;_1'1%9&W19)@)*W1@8;?H)MJ8V+S\^;)@ATB$R17P
M^1,^_<$2)$0+XH3CDJ7W\> RMEC"5G H3'Y7H? SQ+#,18K^).L($<1S*1]-
M(:M8=3M0AZ2>U3P4:O&O.X.QP#O%S^#769Z*6,MWC=TM%#$0HMANABX;/I-Q
MMVT7^\+;'/X[W;[\VQ8P]K$O[[SYI75/I0NM1R5"*UM0$?]2](E)[HZOOW/9
MEUV!$,?81C0),63L$JMD>\-6*%?+_"7/&<&5!@R$>>Q+6(6UTKJG;0[NL&B4
M'A?L_#TS+V/<A]CZ\'U]7>/Z0VTO4KI!Z88F\27N,G&C $)*C+VPA_Q].HH9
MAVR9A*@0ENZ&^)EQ2W&_9K6!MJ5.+(@65&PE[F9N\;W),8G)*7RF;&GBI_'=
M%$K9OH:<D(YE$Y)7A9POOZNUHM_@[S!>$*X1Z^A<YN!:;!SSIGSQG*U\B(D0
MQ?#?'$3#*D0.M2IH09^XG:(>7: LI494#7L.5TIU22/L4#1C#].3DX.F:+X9
MT&^LV5=B:GS6&CN79&N>S0OV+!)_%J\=/0=.6P]=@X/,7X4#B*JF#A%&S+K*
MBFE#+(<@I\?G\AT030LBL,?QQ=\COB)?91SCKQ">V;*)+3?8HHH.5P2E"N5#
MWELB[A&[KPNM_KGP?I\=&(76>'A?)7N_1_EXC^UH>,[$@70/T_E*+,XJ 'N_
M24-,?NZ+1X]=8RPCFJ.#(')RY@HQ01S#MI>UGU/,6YI#6*I/?+JK0EM>\/N(
MC1$G\2%/^['9M,$P5_7A 3X6>\>:*6BP(4;B7K!#^2EDIQ,;[HA!:+BA>,3V
M"'20XI]#W!,.&F2U+.(QVR'MCNB7M]!:*:53E"M6U96W>5G#S@>A$,"VCJRF
MIO.40@5CF7PUOK>\[C5]/N[,7O$9V$3T(+0@_ XY:!0ZN6=\,$7;>&!N89X!
MA8Y&-RN'/[,?;/D2V4F^73FU]S=G<V /*'3]M9O;=A:*T!HG5SP%+NXOLF>O
MJG9@"X(9'5F(/"RM" 8ZGT+KDE7FA*B4L+0]76B-]QA>0%AFP=(5'"83?NEN
M"![;PU(9E@53340PCD&C";V)*$ %AX-C%EH%M^"& [&+X)L]+PARPV%#M9(3
M%K.L!9_N !P.HB9518*_PJXD\'E4^A!Q2=#H@#S!#F:HFC*8Z:>N[@]"*\DA
M^]=>;X%:CM":/G;H!CJZ9$W;SX7$%0.S.X)@) :N&(%P0%L?VS\K9^PD)_]6
MJ._NOZNG.6R,+8E*08OR<0DB^\WPSHXK5\NZ]%)=T#Y(9&\>.LMIPR=(H[NS
M( +.SB#Y^_[;7RTA1*2F&'&LG0Z8LS<00AG"%1T#),X%_;4XXU_]>!_]SE>N
M=K5G;%ELW,_*.H".J&Z&GT2(+4MX?P3KA;6D@2KE;)^D(K:R))8N0(3/G+UW
MJY@82?4-A\SV!CL*,'=$V#K@/:NNIPNM.7:\4EAB[@-P N[FC4*Q!0&D*-CS
M0FNE7/<:#U<C\$7 Z=QAE"6=L8-B=U\K]O*;F0O,7K/'%XE$V XBO7A4Q?9S
M96],QFM!;3K?#3M(LHA_IM.'\8E_*I[RQ5F6/%U\;FOS+?P<OVO%=OLF90K^
MEL";)51\#VSL">7KIKK=T^UY?/[[DM"Z*[!C^-UI7_UH>TQ63!=:V8[AI,:V
MM);EC@@VA;7$::="ZW9CF7&,'V4,$!Q_[,<Q20!V>'>Q)9<KUMI* 9)0"K['
MIY;7AUB/@)PNJ4[MPG+P_(BYN>\Q^#%BD['O3;=EX02X\3 8[HT G*YSEJ1W
M>.PU2Z *8REO.G0GTL7.GKQTHH>";UA50S,!!^6QE(U"A>UYOF+?/!R+L4IA
MFR6W)*.(K"R!*W%HSCZ$='VRRH:N'(0K[ITXOS">IXD[J]:;?V1;)(0C8@,[
MY"=9A7*:G4S<P81M1(C8>9E?Z*BA>Y:.*F)QDC1BG?1]ZMGWC5.BR0<X4 -?
MG5>QE_%'TL5V1:PNPD[2W8;OCRM**,8A@K&,D#E.!U.A'F+(UB]^_+_G8X_*
M#_;]E]!*#$?\RSS<T7UD O$:@OS_LW<>7E)46Q?_$\Q*SD$R&! $5 0#9D5%
M3$P>F"'G'"0C2 8!45 $1<6 (B B9LPY8590GPK*XS,_K>_^]JW;W8,PTSU3
MU3T#?=?JA<A,=U?5O2?LL\\^Z(':*?&9__*5#,&D:$9K*;D/( YV*8SEF*V[
MQ2A[2]T^^%*NGRZ3_Y8B_SG8HD .B #8"IC=I$Y?OY!E]7B;-NCK77#.34JX
M;=ONGPD13;@6&,@,AZ(%E=@.5G=D:-Q1=J!?T[K]M)=A2\-"!WPY$).S-,OI
M(D) PG9.-+8:8D(+=*DEQY7EN6',%-HID- M %F"9Y!(+,3G<#[?>^=KL<'H
MD+)#\HK& (JKC\HQMF&H; 2=CA1[?OXY&*UO[CO /\^7^TG>0F$)@#-*,,BT
M0ZR-/T?+%OUNBCC?!R@/H^=O\B[RUG7W;1=K$:D*-,'MT.FL?\5&Y1UH)>>E
M@Q<-[Z) :^SSM5KN#$A%/H_X 5!+Y(7?2[^ON9_X7Z3:* B<9?*^ZL=&B_B5
M?!_0_8I9*O[#2BZ+W(_R0O/LB&U6W_F,9%*V/?FNNCXDC18 -N)(-X"M/"\*
M??+9D2&=V9(T8_@D=NBM-[Y(^#,.#K3N_\RR!+1"]LG/M/$!A1I\5) X$/Z3
M>XM\%ODT;'(D<ES,Q1E Y@1I*HKXV.C2=*H>;('Y03A!6Y:BK"NJ.Y\+@$^G
MSR/^GBT-$885,-":4>2+)N_%]\C6%#NHSNC:((K^GU(!K6]Y-T\[$-!JKXT-
M0))!"QT3']%4 A$O2R+CEJ./\]#1]J.ZZ)P??X+N4TWGVEP+?Z*+*B.5.C1.
MD"*HZS,<[*"6;%6".K8=[0T=L$)@#Z ,3N\WOT4XJ,7[ 3 "MI*8 W)V\867
MBP9XAP+0ZEIF<D3'M]7B>R-,UE\2O([]E[1.=MD*'SJ?)%6.?F_WK*TNHI7#
MQ-[/C5';4XJ$BOV&8X/%<*4Q2B0>5MO(3N:#?<14V;DSUVL? ]#_64:P*G;Q
M3+C/;IC3#==84#DRJ=&?G A+F[8ROD.\; ZWT'T"F&/*M)T^V-.V/#)]L$HO
M!:7HI'$&GWWZ/7N-ODAW$(MK!&SEN].FX=IU(]I=1V1)HH6""]-T7WEI1\(R
M(B4!K2[P= , Q5)[]^O0= E3#;3:RF4OM222%#PAF_YMJ24VW()I07#"]&O:
M^6%AUQ$C**HSR3FE/?76A9O4E@A@FLAB;V-# "H X6!*P+JJX>N@.LVQ+N:S
M <Q))&FELHRUX (6E@5\?U8PNGS)%F] X>UB MD!>5G_LND5#F@UYQS[P/DA
M$3XHT&JN?4\I!S <:,4/M-K@D#/$4!K:L@$B&8)3EOOJV+RT"1(WP/@FX'<@
M/O$7 "A3EOL5+)-_=I-9XUTP F&.\!GSC-T#S 0LC@[8R%2KIVM5AED&2P4_
M%J1F%\\-_P\3G6GR=#-$6"4^$Y,XA>047PB(71X7!1N^&PE"[_QEZOQR+?#8
M''P:<0B)+VU[L'*42/SZ1R#W$]L)4$)2!^L'X/RR+E,57SK&"#JGZ,I3E"%V
M0FXC$=:18],#)&"WB3T8"EHI)C>PL?H(Q8WWKGE.!:;]62G_^"Q3]!?Y'C#.
M !MAMS@Y+?P#]Y"8F4XP.]%Z=Z Q\3Z1('Z0G L3V0\&M'*]";6GQKD 6KEV
MAM@<"&CE[X#9Z)GCJV%*$_\$,6#U8(N]2$S$7J;%GV(O/IW..@"TH!;OM5-%
MM$\D'4?,!;$%W\F+^!G9.(H6G_KQ<[P@N^O^X/T90E.0=ZMBC=H:>F2!5@9$
M8M^ZJ(BT5L/"V*O[?& CB#/I@&M >G)6GC=Q,IUI)S6V<P%<SB#[T&Z,EY>Q
M4#J7,,E^3T JQ<G3H=M,"SY^WDXXCP5T_(*^L:F77S!-<QBP%9\FJ*E<W.(]
MB$E@3T)L8>@8>[A6C(P3WX&"$_JU_ R=0>3BOP0X\%#ZTK_9XA/%:.1!;#%O
MDNU:DT1>AG=H :T6MZ!009XV9,!*D4/>>O/SA+HE#K:PX^QC<@/R(<T'J)17
MI-#&C #.$R [1=S2+G(LGIU8X<8&.68G\BREE1+9?SD6M,#X^U]4=S/L>G4:
M^WJMK1I9Z06&EY,C)OJY)0.ME@#B=+")'>XT<>3+YDP04_P94-''+=<!R!DE
M-^G1?8ZZ1>F.=_$E;.C+C3\>/6R5!J518 LJY,-_<1;I.H0M[#Z3%S(>%/5Y
M#L]N>R_2]5>:%0C0BO'$B/+02")I#^1P)?>5YPMI#]343,!*@--$@5:!+ <!
M6IU#9 /RX*F44!WD,X(X:!AV*/$81B;AHH\(V%J$L7?::#$ F'K]J3DPB2R^
M(I7@.Y9M$5N/]@EK=&,8([4*O>[F ,)DQ;F&S=@@D(!U01",!@CMM1CG_:LL
M%1UH=7N'MGK ,^YOD, 51I!VO4=\"KQKHXM\OKF?!(H$5@ _-DF(TVG[B;Y8
MLPLWJF6LG7&<$:?M3^8[O^,$@3DP#OXLI89P/(L CB1WQN0'%3S4.-Y)%V2)
MX7KZR<-,\K9 DQTEXT'"'U>KU3]J(5NR:*.7F[G(W"]WC='I@PQ?@4V*7$ 8
MK!*W2#JW;+8Z<02'CG%NY1E(^@9Z/;,6>9L>?UU%GD3:*8H#6BWK($OZ752@
M8>Z1A <%&AUHI19H]1G?#?I)#Q+[X/1*@U@NN :XZ7[5+*])_;Y^D)_AN<X/
M)M)BT]FOB0:#[&V 4R0U^O2\33(ZL4P-_ ?71U6:MC4258"W,!>% I()OA,R
M!B2LUH]E>/LG$Q4):.6L?_75#][++^WP)HRYIUB@=??N__.UJ<K^N?$ K>[<
MPM2A.(*=)A"'@1#4 M"'C:+6Q\Z3([91 TXJV8GR%+GP@__][V]*S.-=)-8D
M 5N?>$OR2#"@L'.Q\@0 @PS0@-7VD?%U82PG_X$OG3/S$8%.L4Q0KKE-J^%B
MO=%!0J&X/"Z*HA0\D$!AR$34QF=89F[U7F*S2>_MO=+IO<6S_L\?T$>\2LQ)
M?(G]<X5#8A22&0 .$O#2=/<0IR+YP+XD-V'PGXM]W&=0\(%9^\3F-_7SL>V,
M*B3\BA3!)TI@+^QLAWA%I[)G"WB$@39B\)W>4R:^B<05 2XZAK[^LGB@E4X>
M\H-]^WX/M(62):!UU!H5ZIOO![0ZG6( $UA_%.Q+XX_+ZQ+ST9>-NGWI$R(E
M,$_!#:@B_^#O^"J8T<1G\0*]["]BM/??^TI[L,U)0S7HU]IO6SQG.*;D"4Q^
M@_VD53^H3K!_7VN4/8?>+]TVR!C0R1B5B\C2664XSKB1JS5XS;;PQQ?O\MU_
M^,]>;\>'WPC((UZU0&M1X+ZFW^(-H//$QK<4_R!M%]0B#R%O(5]@<!KGVME!
MO@O/E>^ 9NMB?TI]6+;0+;1>Z8Q9;^(]_ B2($YCM&AAHR(#K3X#_CC+@ ?,
MIPM A9F NGV<?![Q/7A)&X9UUBR,Q Q<XYEMQPA7('\ E*T(BR(.A3Q\,]T8
MMLO7YJ!T*Y&#]B^\3=>=:#=C/$ KA0=R!H8\4U@G%N)9QXT7E&)A[]!%'S]Z
MC7>EV:=(Y+GX$O(=A2]FI4#Z(3\+(A_E]YU,T W=K)9\[/F@0$L1F)D+#"PK
MRRHST*ID[O@<!=FTE%$)QGC@,&!5]$SB"V--U632N+7&L+ZA!#>1JDD\0.N)
M0M>G">5&/X=VHZ JCM*'W/NK'#D.G;9A]-"J'.6FSV6)20(+ ;U$!D;$N]1*
M9H))DB^H]H H@"GN&6*<8!>@H4+ 2C!)Q2A(FO:!%LX>T(]I;K2;4X'B>S@P
MXE  6DF&&5I"0('0^QSC]-"H87\&M7Z3QLM/8K:A=<+0&;16;,)ADQHT7Q@6
MQ1['V,;KM/_P]^6+9N^,&;%:AKZ9K^'E9 , [;E_. <7$ 19^8I=@,I4%9$'
M0,L&-A4!L9TXG*>!3I=>,,6[?=F38OKRW4OZ+E9#^'>QO6&JGW_V!)_5X2=;
MYG6V"831#:3"1X6\M /IXEFP1! \I]J&/96^;Z5\?0^N%;TT]!*I CH=T7A7
M/$ KTB78&0H".THAP9#(2BW0:H==T*:,W2/9_"5!O;?BEF4#_BF6++I^#!0A
M6(I63K.]3N9[T:K*O?X\SC;,V $T)!&<RRLB.K 6D"?(Q98B V.#Z8_%U(AG
MPG=9%O>/@B$:C; ) "Y@NUN]V#30FN@J&6BUS!'L/<D&>X%]C(T/HOW2+=C6
MQ \ C##[K#R-/Q 5::-J/65W\0%.KS'>ZR=X?M^<;VPK\ATPZK%S;N(ZS$1\
M)RUSV"^ZE<):?&<2?N)=BFJTMSN-6,MTL,Q:=Y\3U61+QJ*@3KO?(!./G-EV
M= S[.%/?'S("0QP9\ "X&21[*W;A(^F(@@$$B,E@"^).=S_90Q2?T8T&8"Q-
M,@P[GY@#MA03ZDG*&OG#L1RS"?O#_J'0C"P,,8'3NX1-\^8;GVG?,FP35JS3
MDX79!YL5D)68'\ #W_^_!&84Q+O*'] :+=3S/2C>PTHF/\*GEH4A5MZ68Y,1
M]Z.]>^,ULWU6:Z](_$>..Z3_2F^;N4^P+N/UHP!KZ)RBJTCK.GN3UGPWO T[
MSN!"<IMEMSXA/VV98P?6OP]B.:U@2"XPVOE>Y$158W2.87036_.]D%-1=T2<
M.0LV\?M8H+7)_D"K'5KDAAHB0T$.2!$XR'W-\P0\G3?[4<E](:'DV.[5CLD6
MF$S7 K80NT 1IJP=AB4M6U3\102&6V8\H@ZY:/?&H02T9FJO4R!E?\$J!43\
M]=?$9>L.M%PG @5%""&7F=A#F$:,?"7WE>(OS[\LVO')7-@+SAKL[L+<I<K[
M[.#3+*^!3R3*SUJD(DFBL4?Q0*M]9G2^M#6VC_P0G_J]/U\EC**/6YP);!%=
MU+;0/M GW&4ICV%F$)WJ^!Z 7]NE57J2D\/#7GS^0PWL1DZD2+YO;" =B#>-
M72L9P;)V+I41:+7!$BU [5N/\*[I.M.;9(*IA]>]K"E['"R"AF2\$&1'6XFD
MDY9L]*9X>(ELPGB UA8-!TI@&: 3-D.0B8S3*<,IHT<$0Y !&Y&*AKG?&%Y:
M'$#9"5[C723D5))X+MDWS%<5#6<?.YT>(,F"*\\(; P*0"YN:;B!*KZ_BXV)
M0<;QVG:]J..IT$"K,62 Y8"33#4&Q":A"+)UUP6)&%&2"2K1!!&QTU-ANW&-
M:XWQI$(3+PT>(PL83@4VZ_KY8L/8)-A)6N2HS1Z'&QE"%>*V 8SY:<\^)>:3
MQJ_U3FXVR*MGDGR^B].]A+W+$ R"$\"EDM@G@*R[3;*/C8/9V*1>GPC8[R89
M=^]ZBZJR!"4$D6&>#?8J#I?@$T9!:XHNYGDZ<(/]!("&G6 R:R*3ODL"6OD,
M]+( 5&BC*HN&<#PK=4!K5-<7H--*)'R5L+YD<<N!9&BS6:W"Z4KZ8Z\1YC0L
M<;HP +7C>]]_?'VCW\0<!71OW7R(5Z=R?@1<H!+LVLCQ5X!?=GA9N#;=#GG\
MGT3N[S4!'<^5F.% FN=IH+7D53S0&AUB0E),S #;[/OO?A9P$X1VF%N 4_@M
MXBUTA?''1?2&C\U66S',('Z.0FV\>^T+$\C":$"CCXF[46#3#@)MW6*(Y(R<
M?E_0(-/^"TU:.C_4SG;MO(A$CNLHX*QE73]/+/1$M47#7MSS[<;>X!O1>;.#
M5:/)YUEMQRB.8J B[<EA@(:QWP7 "#L,H ,;DL2;.0?._@$RY?K,$9@\B2X-
MG3'/ &;NPGD;-)D9-DK5HW,C\1VVD*(3=A*IJEV[=HLDP7?[Z,.=ZJAB(%BG
M#N-DIZKX9ZLN0ZA,W);KRQMP!DGRPC"AY1-HM8DXG8K$0\0,Q.G<AR U4LO+
MXAP#<,#R)-$^4451V[7%H%ZZ1M8__*IBD7B+$\2*)/0,222&K'I,E''MXN?.
MQD_/GKE> YL@!_R3I,(-L1W#MK#9D&_H:JQRC!MR;66' .@ JLBKXY6K<T K
MN=148].+ JW^O(KC\W7>>F4OEIV%^?YW@#DG[T,,31MV0>ZM8NC5JUX0Z5"C
MP_"T%D/5M4 !CVM+%#,H[??"[E"HV+#^5<6%%.ZBI*=# 6BU,2BV_0:3;Y.G
MD'<$CBF8MZ(+D9@G/[8+T6>  KS"3I\\8:TZ)BK"PI>1LY)[#1NX4HQ@; 1Y
M*/X(3(A"$-(MB4HT%0^TVF?&/2.?![Q&8SU,TI1;V LGW3+EIOL$)KOXT@[/
MRU$<"'[R_#,?2,N\+"1 S1W8O4_S9G(S%JI;(:+O?J0=5DRL@/P6.O 0 <JR
M @!:LR6:BQ'KF;-8P1L& =0Y::_W=ZK*S'\3X(,^[Y:&3F(5P0,#K5F11(*'
M30 W<>Q:7X/R^U "; PPQHN $4"P>DQ02NL#(N5\1YQWO(M-Q; M@DRK/9D?
MT0IT^J^ *X@\<[A*H_]:EL5AQMC30@9=&S#"@DK12945%6CE>TOCZ=01 O](
M;A!:#[+MW $O &Y,^B7A);%P^J)V[PPV]X\VBJU*(O^*\_/%^'C],^U)G+75
M7+0 +FW!Z,X"YA T$"0&V:YZH$600DLVU\I^Z=)I@EI-79L7+_34&(J%UA6.
MI20 A^?WH4G4EB[<I( 3H^L&%_'?L!#[%2P7,Q$ :5_HUV@'%_#=T:.%:8XV
M:]5CHVTDM/'!4*; 1 4TWG4PH)6SAHU#1Q3G XA A;\T0_<26:D"6IU>(;JF
MZ X_:7Z.]N@P%MJ3SK;MWZ+"1&YTE]!Q_2#.JCN^C>?RI?F^[ _ "PHKU7W]
M0VPG6JT4#=#Z??JI]P)ET,>S\#GX21),P"K8059/.:I;G09:2UXE ZT6_(.!
M!6OG?N/C?M64Y& DC=QRDW&)#P B:E?)TW3A:!MXIMF'H[7?2'Y(XN/]?'Y^
MA3GC%+'QS2X9YD\Z,=!@XWTIA+@)U&$N8@O:'&%\$A>0H$NOTWR?FL;/-*I=
MJ 0=%B2^G)\/NX 1S^+>4#2$/=<[?XD&PU*@B^T^Z7KQ=&F0X\N2%>?!0*8#
M#/#WL@NFF7N95X0A#"!,VR!@7[Q3U6,7/\]^8\@K9X1AHPQ@@0V$QIW3X4;_
MC2%Q^$R("AJ^9NX50Z N-]_!=7FYP;"<*?2" 0KX^:"&]!QHE4>@53K?1V8I
MV2?&(M$E[Z 0$=9]2.4B#R%>@.7$/FU2MU\4:*W91X/0B/,!)^/-/[XRN<I#
MYG?&FE@-#=;8+D*>*]JLZ%XSY%4=6*68CE[:A:0!0RP!;91W-1T4(]EB@1=
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M.5]T>5C[7;[MEBT2_*7<A2)$2Q/KU6,PG['#Q)F @'3&4?B \&.QKOC>^^!
M:[0 TKG#.)$)'W_L=6$RR5C8%'P*V!T8%#@/4@'87)YEY2.S59Q%FA1\B,YL
M]G9I%WL&>SM]\H/JH')=!KS(]SNT'B%?B(QG$(,G P%:&<# P!:T#=GP8;=U
MA;4.#K3:1(I$L>O%T^08"%!QBF%41ZC,$PB3- %@"RSS[W6S^OTUB(ODE(T2
M[\+A\9XC!J_RVI\ZRC=&EH6"<2=Q&S[H3DWV3$9KWOZ+^TB5 <=(&P &VK%N
MW?>LF$"KG5B+?O'UW6Y1LAAFL+Y;X..S7M8-\S4UE)8Y![0V-T%CCVOF22,6
M^GV\H ;:-G>MW.;U-_>'86RQ(!$:.-V[SO3FSWE4%2(GSIV,%\4 6)?(75QH
M]DM]7U>-[T80E7'=?"51./F2]+0(8G!<@TQ00V#IG#5)&FVK5,1A))+(X:A=
M933L%TP@6O4 -BX^;XI7LU+/HNSV:^9*VS@1=ON!@%8Y,Y.,DIBV.W6XM#4!
M-O_X(_R$*E5 JRTPY9M@?X'TCG;!Q@Y)GPM--PT2&G6/BF=%VIM.'&@"Q)LT
MG1=F7SP+4 && /8*N^4FHW-M!.HU*^4JN9@Z\7[OP_>_ED\):W#;P9:D#4SR
M1&#'4#>*%;!N72=%&FB-;Y4,M-INA1N[.UOP4=D_] #+R=-@Y[$/,-P:U'")
MH4VN8-ESUK!'V,J26F"=5B#@</^"V\2 D8:Q#T14.3HG G81[SB6;-@OUXY.
M0,X]9>\R+*9:A#&>J4(FVH($XR218>EUQ[OXWA0?89TM6;C).Z_C> &K3E('
MP+6^>5X4T7@^,-FL7EYR?#7%)A(DAF+!&JGL3UP'1#REV2 [C'#M"P(@[""@
MQ*[?[4\*4,3H%"?Q)S#7V$<D:\1#;4W, AL95C;["H#WE.:#(ZV*@#$\:V(;
M-'K9F]@P@- P5[D$6BDVFR24+@R&D=RZ<*-\:GE9__P3M2'<#^(\ %#RLSU[
M_D\%$  _F(WL"X9803K!-G$=2)9\'O/B[!"C,_2,I-XR6K,B0&NO["7Z]S?C
M %J=':$P11&)%N:(AJ1OW^AF8=_#F$8F*E6+^)?X%FDP[%HLT I)!# 8/XT$
M4CRZD,4!K=&9%06*79[<_+;)^[X-5"?:L5DI^-'9QGFN0?OU49D1AAQ:S".'
MK#+GZ2UUPB8[YU5GGOF>GW_^']DA"G<4-)!5.2%&*K!B :VQ':C9_AR)IV7[
MR4W#6)QK\EDZNS3XT>_RX=7 EQT::'(+\D#N=UA^FO-.X8)]A!_:%[%#^\36
MIC,T8H>^+FJ'8FT0X";^9OL+.[1W6QB[#P'&%GCMP/+++YJJ/!^_ZK3&XUG%
M :TNK@%[08*'/!&YL60NKN,%$YM,-7$5<P TE/((5_#+D<P;V 92']CJTDI1
M<)96K=@FR;C8#BJ*BJ<;7P=C&'O(O2IMX3=V!0:T7G+^5..<[A+S[5 #6GD
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MS*MFI7SI3Q?D+1'81["3S&ND3>^1!U\2L,%WJU4Y*H] @8NV6AB][-MXU\&
M5FP!9XYJWM+%F\3F2L9*#=":)=N";A>L)5AI85:[24Y)9)DR>V'GR46 UA8-
M!V@:=R) *^><]YM_RZ.:IFW/N670T_X*@(E-7VT22?2,_R>&6&I:FP$^2$X9
M*'-VN['FNQ9$0.$TT%KR*AEHS=(0B!%#5JD(#.,TC*7$T.RCKXQ=H"OBK+:C
M!,B(Y>D#K=B/\:/O];9NL1.<BP=:_Q$#C;W,M%F2!Y(*.VC1)@ ,9LDPR1J
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MEN]*!J/5#9'BLR"VT/K-P%[\&@5%F*HN_L3N,C^#-G2 ).X/W7DS)C^H(5F
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MJTU(='V@%0?$D(#"W"7>FKN2-P"GN+7]Q8]4U;GLPJD:)&6!UHH[# N@M1=
MZY**![3B(#='-%J'2>0\%FBEW>ZZJVX12$903$4HU2]TGY8LW"P6"\'6CH]V
M%7NM!]9H95]8@PYXT.WRF[W^O6_SIIM[E^KKBURC2?(93H .)\XSWA4/T'IO
M&F@-=(4R#.NAEU6=Q??&#L-B_Y[5=K27E[7(>_C!EQ1DI!)LI3J,_YEDKH_I
MWU:#+ VTQKL.7:#U'^UC] EA.S-H$!_OP%82<]KF+NATDS?4Q#OX%P#95-M>
M:W\W>'<LV^H]L?$M,;QH?PU+@R[>935:/S6)Q_X:K7;2]XFU"E4LO<'$/\2Q
MJ;Z'[H4,!79QM?%E@%][?_Y5P$MI;1:_1]LY2:@=PO> 8A22J<K^-/7*/GB$
M9BU[SFI'6OW:#J>-%. (*(=?)19,AOTLST#KM1&@];W0@5;R,-J-:=.]OML<
MKTD]GSUVA-5<92_7%<N]O_P<>1EY*?X%]BO *E(1["6*.$RP1A+MISW[)"$%
MV (X@3W?WS?R=PHG^&+>%]U$YU?+I-%ZV8S(]'#'H ;D .Q VHKX _9UJI;5
M:/W.:K1>.U=G(Q84YKM?TF6*0.A//O[&V[.G]!JMR0!:R<?8 [-O?D0Q1PV
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M/A*[#QVP0K$O()F+(?BNIY\\0MUL[']:JN/)7U(-M')=%)89A@N(B30>S#<
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MAH7^^^_!L*X.!Z"5A)B. O;F2&/CSFXWIDAK&/N8I.-:?V(\,0P)%K(J82R
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M"S9ZW4W":UDRYO[Y0Z,(6DBT&1J%LWCWG2\CS(-@6FCM_B$AIR6 P)@@D2%
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MH)DX;^B E=Z+SW^D(C3[I2R+/<Y^YYD#U,R8O$Z:QOCC:L?F1FQK68%6M]
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M,R''XHI6[$'BNHO.G22@ K_/?2H+\U#,-_/[Q,T %&U/'J8N -L^:C\7Z0R
MT!&#[A+8B+XM9^4;\]G.OJ!/_^G'W\F^O"N[_;EF,Y1D6U,+M'J*1SF; -P
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M&O'=LH4F?B>.=[:0V)[_)JX'P.>S\/%OO_6%&/5T^] U@)8T16X^![O;JM$
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M6FVAS0[)@TG>I]<R^4OV0K5CW;!N&^<A(W#6Z:.UCQCL"#F!WR'FH,N![C"
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M39D'UKX@X*K;%3-5]<40H$_),Z>J4OUXJWE11<FE?56*O++U=Y(5!@@!5C-
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M32?YYG>1"2 1@37 >V/3 2#???LK,0((5@G8T$4C&88U6Y&!5K<H"'*.L'D
M>M*F51#N]' S(D-<;.MK%"2P_Q\FG@G^&@U1\C]A[#T"\0ZT_L5H!6@]L;^&
M-+E6MI0R6H_+%?C#"[\Z(0"@-?J9GMKPT#,C+B'N$?NKU7"U8.(+9$>/CMI>
M%R\ 1E%48'@$3 W\#(PN9&>J'^>FBMOG@^W&)G .I(5=JX_\"]U9="B0Q+UL
M[NV^)+(@PEHD6C#\8+L!. ,F<89AU%B@.=N7&7'W-#,R!(1V9N(R[B<)9OWJ
MO?RA+ME%]KL&-QZ3(]_(X"C !AC)-W:?XRV8NT&)_==?_5!BLH,-0[<3F0?
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M; 2OAGX]4XT'?S]<R&\BR1A)&2F)AB1!?B&W];/=>==+9?H0S6:%M*&T/YJ
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M1/@38A7R \>'8(8?&):V8.2YI/US_KD]J7L\D!W1W\L7NP\]KVDDXK/J7GR
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MTT3B:53_Z619M'!C]MZ@P6 P& P&@\%@N*+PV]+-TM?Y#O@0#Y1MEE3]S/5
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/9WJ[     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140617847769536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 23, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 23,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1183488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20 On Hatch, Lower Hatch Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">438-1700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001613103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medtronic plc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 XH02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member', window );">0.00% Senior Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.00% Senior Notes due 2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/22B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230.375PercentMember', window );">0.375% Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Senior Notes due 2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/23B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2023Member', window );">0.000% Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Senior Notes due 2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/23C<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member', window );">0.25% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.25% Senior Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member', window );">0.000% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Senior Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2027Member', window );">1.125% Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.125% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member', window );">0.375% Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Senior Notes due 2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.625PercentMember', window );">1.625% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember', window );">1.00% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.00% Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member', window );">0.750% Senior Notes due 2032</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Senior Notes due 2032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20392.250PercentMember', window );">2.250% Senior Notes due 2039</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.250% Senior Notes due 2039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember', window );">1.50% Senior Notes due 2039</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.50% Senior Notes due 2039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member', window );">1.375% Senior Notes due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.375% Senior Notes due 2040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/40A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member', window );">1.75% Senior Notes due 2049</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.75% Senior Notes due 2049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member', window );">1.625% Senior Notes due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Senior Notes due 2050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230.375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230.375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20392.250PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20392.250PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>mdt-20220823_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdt="http://www.medtronic.com/20220823"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mdt-20220823.xsd" xlink:type="simple"/>
    <context id="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i3afecaea79784f64820dd39c3de82568_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i62e40b0d60f74b66beb6116092511379_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.00PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20391.50PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <context id="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-23</startDate>
            <endDate>2022-08-23</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN18yLTEtMS0xLTg4MzMw_7365726c-476d-4797-a1cf-58d517768089">0001613103</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN18zLTEtMS0xLTg4MzMw_a5c4a1be-8db9-4f83-b6e9-03047a7dadfe">Medtronic plc</dei:EntityRegistrantName>
    <dei:EntityAddressPostalZipCode
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN180LTEtMS0xLTg4MzMw_324765b8-98fc-4b61-ba86-e87c81b6ff09">D02 XH02</dei:EntityAddressPostalZipCode>
    <dei:AmendmentFlag
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF80L2ZyYWc6NWViZjFkOWYzZDVhNDg1MmJjNjQ4NGZmMzFlYWE1ZDMvdGFibGU6NzM5ZDE1YTc1NzJmNDI0YTliMjExZTg0NWE1ZTJkZjcvdGFibGVyYW5nZTo3MzlkMTVhNzU3MmY0MjRhOWIyMTFlODQ1YTVlMmRmN181LTEtMS0xLTg4MzMw_b30043bf-722b-4454-a1dd-94de86cec9b6">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV8xMTU_5abae5f9-8d8d-4045-aabb-15ebb761039b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV81NDk3NTU4MTU3Njg_35863908-b249-4191-8738-8227c9b5d711">2022-08-23</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmY3NmFkYWNlY2RmNDUxYmI1ZDY5Y2U1ZmIyN2ZiOWUvdGFibGVyYW5nZTpiZjc2YWRhY2VjZGY0NTFiYjVkNjljZTVmYjI3ZmI5ZV8xLTAtMS0xLTg4MzMw_e28ed376-c672-41d8-9b63-708f6ac60846">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmY3NmFkYWNlY2RmNDUxYmI1ZDY5Y2U1ZmIyN2ZiOWUvdGFibGVyYW5nZTpiZjc2YWRhY2VjZGY0NTFiYjVkNjljZTVmYjI3ZmI5ZV8xLTItMS0xLTg4MzMw_5056ace2-4e83-4f19-aa18-5de3dd00fd07">1-36820</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmY3NmFkYWNlY2RmNDUxYmI1ZDY5Y2U1ZmIyN2ZiOWUvdGFibGVyYW5nZTpiZjc2YWRhY2VjZGY0NTFiYjVkNjljZTVmYjI3ZmI5ZV8xLTQtMS0xLTg4MzMw_008a770c-3f65-4e2a-8e08-dab2ca3ca359">98-1183488</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80Mjg_977656c5-c53e-43a2-bbf3-816abd0ecf6e">20 On Hatch, Lower Hatch Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80MzI_2da2e861-9df4-4bef-a7ed-cdb9e756ac38">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80MzY_124df11e-d5ec-49e0-8aa6-eb2f85dda198">IE</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80OTQ_c9ffd38f-4489-43c0-9633-379bc9ef0f84">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV80OTc_f4832577-8426-4b6d-bbac-30265065a15c">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV81MDA_d907bd35-169c-4c97-b37d-c6de75a16c09">438-1700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6OTE2NjlkYzgwMjA4NDMzNWE5OGEyM2MyZmU0NGRiZTAvdGFibGVyYW5nZTo5MTY2OWRjODAyMDg0MzM1YTk4YTIzYzJmZTQ0ZGJlMF8wLTAtMS0xLTg4MzMw_1f52b516-63d4-40ec-b2e8-a961315489c6">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6YmRkMTc0NjVhYzdkNGFhMDg2Mjk1NzNmY2QzOGQ0NTYvdGFibGVyYW5nZTpiZGQxNzQ2NWFjN2Q0YWEwODYyOTU3M2ZjZDM4ZDQ1Nl8wLTAtMS0xLTg4MzMw_ff72aa02-160c-4559-b3ed-113fcdc450c6">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6MWRmM2YzMWQ0YzI4NDI4YTgzOTViOGY1YmNlNTViNTAvdGFibGVyYW5nZToxZGYzZjMxZDRjMjg0MjhhODM5NWI4ZjViY2U1NWI1MF8wLTAtMS0xLTg4MzMw_e8c32c95-a474-414c-912e-26223e76ca2a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6MTA0NDEzMWI2MTk4NDgxOTg1NDI4OTZlYzc1NzQwYmIvdGFibGVyYW5nZToxMDQ0MTMxYjYxOTg0ODE5ODU0Mjg5NmVjNzU3NDBiYl8wLTAtMS0xLTg4MzMw_47838a11-9485-461d-a7ab-b4cfcb4b633a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xLTAtMS0xLTg4MzMw_9b1962fe-2a04-42b8-bc9d-e91036c2843b">Ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xLTEtMS0xLTg4MzMw_0380b738-514f-48cc-b57f-05bf5d5d767b">MDT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie4a9f4b75e89442dbd7ba79a44ccf046_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xLTItMS0xLTg4MzMw_e5bb8638-b22c-4d54-b3cc-764bc553214e">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8yLTAtMS0xLTg4MzMw_d8e514d9-63ff-425f-88b8-0e8bce98e0b7">0.00% Senior Notes due 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8yLTEtMS0xLTg4MzMw_55cb78ba-e70d-4de3-a07d-517c5d4b3e94">MDT/22B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifb9aa2db8db241cb94ffe95f49a89b06_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8yLTItMS0xLTg4MzMw_07f91c62-d2c7-4629-9aa5-f62da9f48184">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3afecaea79784f64820dd39c3de82568_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8zLTAtMS0xLTg4MzMw_8a1822e4-6e74-4400-b6c2-817c7835c912">0.375% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3afecaea79784f64820dd39c3de82568_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8zLTEtMS0xLTg4MzMw_1f2475d6-4e1b-43de-860e-3f27f4b91c31">MDT/23B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3afecaea79784f64820dd39c3de82568_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8zLTItMS0xLTg4MzMw_895d1767-7141-4719-9b08-4cd053f8ca62">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV80LTAtMS0xLTg4MzMw_7fd9e457-8327-41c5-b092-5f3b4cbc3c96">0.000% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV80LTEtMS0xLTg4MzMw_9af82e07-25c3-45b5-ac61-57d8b60f8a33">MDT/23C</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7083ebc9564e4e61af2ce11811eb218d_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV80LTItMS0xLTg4MzMw_8d9d556e-a979-4e06-bae1-78bc0478726d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV81LTAtMS0xLTg4MzMw_6302aaf0-1920-40dc-b0a7-3ec8c90728d5">0.25% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV81LTEtMS0xLTg4MzMw_d9dcf2d0-e635-496d-9a5b-e8fc0e7c7ea8">MDT/25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8d6c2d71d3da4ec5b2c75a01d3cd906d_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV81LTItMS0xLTg4MzMw_67e49451-b41b-44d0-87e9-c20309a245ed">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV82LTAtMS0xLTg4MzMw_02e7380a-28c3-43d2-a01d-26a8f6d16a34">0.000% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV82LTEtMS0xLTg4MzMw_589801f0-ba6a-4240-860f-5ad727fb4fa8">MDT/25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if7e7d185d1aa497ca88eb5b69a193f27_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV82LTItMS0xLTg4MzMw_574b7a83-13ed-4e30-ad6c-3db9343df6c6">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV83LTAtMS0xLTg4MzMw_640501d9-3958-4a75-b5a5-83406dece793">1.125% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV83LTEtMS0xLTg4MzMw_f084067c-3f1d-4dde-bfd9-b4df2151c06a">MDT/27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie8cd18aa027a4931b6a8d5078dfb6e58_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV83LTItMS0xLTg4MzMw_612d7678-57fa-460e-b50d-e1e7e92e000b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV84LTAtMS0xLTg4MzMw_2aaec3c1-eb86-41c4-b67b-cbc2ded897df">0.375% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV84LTEtMS0xLTg4MzMw_a03327cc-3aba-4a29-b95b-1c01be45447f">MDT/28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib60f29d50f1447609ad081e26e25aa9e_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV84LTItMS0xLTg4MzMw_d2db4217-1619-41a4-8656-c41a1c2b8581">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV85LTAtMS0xLTg4MzMw_6b50028c-0bda-4ae7-89bd-5fc5af7467dc">1.625% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV85LTEtMS0xLTg4MzMw_97c85e93-0398-4d8e-b424-01d3c7d88148">MDT/31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie1a9e300ac73441f8612d94be0f194e5_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV85LTItMS0xLTg4MzMw_8caacbae-c61c-40f3-a83a-b344022afbb7">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i62e40b0d60f74b66beb6116092511379_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMC0wLTEtMS04ODMzMA_80bd5696-4cf1-48be-bdbd-2d6f9affe445">1.00% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i62e40b0d60f74b66beb6116092511379_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMC0xLTEtMS04ODMzMA_3f3b9d1c-eb33-46b8-9642-8e15296c6021">MDT/31A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i62e40b0d60f74b66beb6116092511379_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMC0yLTEtMS04ODMzMA_b7cfb81e-da99-48f4-8d11-0235e47a1069">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMS0wLTEtMS04ODMzMA_227529a3-b026-4b8d-ad45-c0e273e855ac">0.750% Senior Notes due 2032</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMS0xLTEtMS04ODMzMA_9c4f00a6-9d14-41ec-906e-9ad27b2530d0">MDT/32</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9e929b07681e4f9b856a888c092f0c66_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMS0yLTEtMS04ODMzMA_6d038717-e522-4b9a-ae7b-89bc5499f42f">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMi0wLTEtMS04ODMzMA_9cda6d8c-03e6-4007-adf7-848964928788">2.250% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMi0xLTEtMS04ODMzMA_15b1d66d-5d6d-4d66-8b40-068377d2b3a4">MDT/39A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie007f82d89ae4eb5871d43ef55b0be35_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMi0yLTEtMS04ODMzMA_936a30d9-e0ec-494d-bf87-7a6fdbe74bd9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMy0wLTEtMS04ODMzMA_27322f16-580a-4bb4-a582-11f50d8a751d">1.50% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMy0xLTEtMS04ODMzMA_3ee8c3b6-1b32-4143-90dc-9aa0fa46f68e">MDT/39B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i86bb9b13fc1e4b608cb4302fbef25b84_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xMy0yLTEtMS04ODMzMA_6723ff3c-a20b-495e-ae66-e47657a901aa">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNC0wLTEtMS04ODMzMA_d8a2fc1b-7bd9-4adb-ba36-714163dc22c5">1.375% Senior Notes due 2040</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNC0xLTEtMS04ODMzMA_88dbafd1-bfb7-4cbb-8fe5-1ee6fa925d25">MDT/40A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i997ec3ef7f004fd685716d1a7c6e71ef_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNC0yLTEtMS04ODMzMA_93250aab-e78a-40e2-9767-1a66defc9198">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNS0wLTEtMS04ODMzMA_e842e2c3-7ccf-438f-9d14-e373f48cf377">1.75% Senior Notes due 2049</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNS0xLTEtMS04ODMzMA_fed4a5d5-7e04-471d-b293-3cfc5b9ffbba">MDT/49</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib7c2a30f237541aeb0664edd6191e418_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNS0yLTEtMS04ODMzMA_472872fa-af11-4333-82c2-a47a7efb06d8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNi0wLTEtMS04ODMzMA_3becf04c-7cb7-4941-95a6-43632c79d807">1.625% Senior Notes due 2050</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNi0xLTEtMS04ODMzMA_b5638204-2622-4d5f-ab26-da8c519812d5">MDT/50</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie82f878fc02e4700af4cb17ea3334ed0_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGFibGU6NTQ5YWNlMjc1NzYzNDdmNTg0YzNjYTA2YzBkMDVkYWUvdGFibGVyYW5nZTo1NDlhY2UyNzU3NjM0N2Y1ODRjM2NhMDZjMGQwNWRhZV8xNi0yLTEtMS04ODMzMA_fdc35b51-649a-4a53-911a-ac37bf042ce7">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic9310348059447ea887254a14f9e2bb4_D20220823-20220823"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxZGI4YmM4MjgwZjQwZmZiNjNhODI3ODJjMzVjMTM0L3NlYzpkMWRiOGJjODI4MGY0MGZmYjYzYTgyNzgyYzM1YzEzNF8xL2ZyYWc6MjI0MDk1NDk5ZTFjNDdmZmIzYjJkYTJkMTRkZTZjZTUvdGV4dHJlZ2lvbjoyMjQwOTU0OTllMWM0N2ZmYjNiMmRhMmQxNGRlNmNlNV8xMDc2_d8ff57df-3c0b-4860-b799-fd8bc7d1ae67">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
M  @ ZS47513'P?$;"   _D$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6RUG%ESXD84A?]*%UDJJ?(8[<O$ILIC>S*NV5QC)Y.E\B!+#:@BJ8G4>/GW
M:0G,A1GI7@VT7@P"^OC0M\_])($X>1#EO]6<<\D>\ZRH3D=S*1<OQ^,JGO,\
MJH[%@A?JF:DH\TBJS7(VKA8ECY)F4)Z-+</PQGF4%J/)2?/8=3DY$4N9I06_
M+EFUS/.H?'K%,_%P.C)'SP]\2F=S63\PGIPLHAF_X?*WQ76IML8;E23->5&E
MHF EGYZ.SLR7KTS#JD<T+_D]Y0_5UGU6OY<[(?ZM-ZZ2TY%16^(9CV6M$:F;
M>W[.LZR64D;^6ZN.-O^T'KA]_UG]=?/NU;NYBRI^+K+/:2+GIZ-@Q!(^C9:9
M_"0>WO#U.W)KO5AD5?.7/:Q>Z[@C%B\K*?+U8.4@3XO5;?2XGHD^ ZSU@&8B
MQJM_U+B\B&0T.2G% ROK5RNU^D[S5IO1REQ:U&6YD:5Z-E7CY.1<W//R9"R5
M5/W .%X/>[4:9G4,.UO.CIEE'S'+L*S=X6/E8&/#VMBP&CV[0^^RD*E\8E?%
M:J'5]?K[G7H-NY(\K_YI,[@2=-H%Z]7\LEI$,3\=J>5:\?*>CR8_?F=ZQB^(
M77MCU\;4)Q<B7JJU*=GMTX*WF<.'!R_>(B:<C0FGGXEK7J8B89=%PM0::/6#
M*VVJ2973W5AS4<%-.6-1+D39%/2(W4CECHF2G8ME(<LG=9NTNL7%WV$.O8U#
MKX_#UVG&V8=E?M<> ES#?&%[@64@;OR-&[^/F]OHD5TEJJ3I-(U7*>CVABN&
MP0O3#&PG"!![P<9>T,?>69*H*%5'SW=8D]"/16L-<47+4./8FTC&\R/V3CSP
M<K6AUDBI6AGB.=QX#K_)\WF]I=;>K7@HVOSB:A?+._40PU:>:4#+-;[-VBH.
MK5T85[JZQ QM,<!$99[S^(G/U)IK]8$+V*Z-&0$*F&C7GC1%.E.[%YVM@1 P
M,1O0W4V\/[\3<92QZ[DHL.9 B#BVBJ!O8.W!A%9OXAWZ<YE*R0LU+7F^+-;-
MH6IUA0M-HZSBF"5H\2;>AF]$EL:I3(L9>Z_Z>IE&6:L?7(7T PW=Q+OQ=<E?
MQ&IZ>!'S%9MYD:B^\G$Z[:@?KD<Z@^9NXKWX*V=75;54SDB#N"QI$-J[V:N_
M7^:\G-7U_%4IR'F]V!91T=Z7<$'2&G1QLU<;/U?35JI,7JD9>V1O>;LI7,HP
M#-,S;=/ >I4%7=SJU<7KGEDI;ZJL'Z*\M6<10N]Y(DNA0LT668Q9@WYNX>WX
M2\!<BTJJR?LK773V54+QPK#8'V\,=%=_:U\?;])G*@1)$X37631K=8,+4,O+
M@DYOX4WZ8YFDA3H<9=4\4G-UQ!91R>ZC;,G9]\9QO6+80D6T>;;5*"J_YU&(
M!5BP'.V'32@?]G4,U+#P?G^;2K7'+:;,M'ZZ^YG=\'BIT-8:9T)I_]+M6@?
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M3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;
M 4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #K-1=5EXJ[',     3 @
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MY68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B?
M:ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G6
M0VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_
M,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #K-1=5)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ZS475660>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( .LU%U4ZDO7K\    "L"   1
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M96QS+RYR96QS4$L! A0#%     @ ZS475:K$(A8S 0  (@(   \
M     ( !)10  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .LU%U4D'INB
MK0   /@!   :              "  845  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( .LU%U5ED'F2&0$  ,\#   3
M  "  6H6  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  +07
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>17</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>16</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mdt-20220823.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode, dei:EntityRegistrantName -  mdt-20220823.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="mdt-20220823.htm">mdt-20220823.htm</File>
    <File>exhibit991-fy23q1earningsr.htm</File>
    <File>mdt-20220823.xsd</File>
    <File>mdt-20220823_def.xml</File>
    <File>mdt-20220823_lab.xml</File>
    <File>mdt-20220823_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="68">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mdt-20220823.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 17,
   "dts": {
    "definitionLink": {
     "local": [
      "mdt-20220823_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mdt-20220823.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mdt-20220823_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdt-20220823_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mdt-20220823.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 44,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 15,
   "memberStandard": 1,
   "nsprefix": "mdt",
   "nsuri": "http://www.medtronic.com/20220823",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20220823.htm",
      "contextRef": "ic9310348059447ea887254a14f9e2bb4_D20220823-20220823",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.medtronic.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20220823.htm",
      "contextRef": "ic9310348059447ea887254a14f9e2bb4_D20220823-20220823",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 16,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "mdt_SeniorNotes2019Due2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2022 [Member]",
        "label": "Senior Notes 2019 Due 2022 [Member]",
        "terseLabel": "0.00% Senior Notes due 2022"
       }
      }
     },
     "localname": "SeniorNotes2019Due2022Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20230.375PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]",
        "label": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]",
        "terseLabel": "0.375% Senior Notes due 2023"
       }
      }
     },
     "localname": "SeniorNotes2019Due20230.375PercentMember",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2025 [Member]",
        "label": "Senior Notes 2019 Due 2025 [Member]",
        "terseLabel": "0.25% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2019Due2025Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2027 [Member]",
        "label": "Senior Notes 2019 Due 2027 [Member]",
        "terseLabel": "1.125% Senior Notes due 2027"
       }
      }
     },
     "localname": "SeniorNotes2019Due2027Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20311.00PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]",
        "label": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]",
        "terseLabel": "1.00% Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotes2019Due20311.00PercentMember",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20311.625PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]",
        "label": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]",
        "terseLabel": "1.625% Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotes2019Due20311.625PercentMember",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20391.50PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]",
        "verboseLabel": "1.50% Senior Notes due 2039"
       }
      }
     },
     "localname": "SeniorNotes2019Due20391.50PercentMember",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20392.250PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]",
        "verboseLabel": "2.250% Senior Notes due 2039"
       }
      }
     },
     "localname": "SeniorNotes2019Due20392.250PercentMember",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2049 [Member]",
        "label": "Senior Notes 2019 Due 2049 [Member]",
        "verboseLabel": "1.75% Senior Notes due 2049"
       }
      }
     },
     "localname": "SeniorNotes2019Due2049Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2023",
        "label": "Senior Notes 2020 Due 2023 [Member]",
        "terseLabel": "0.000% Senior Notes due 2023"
       }
      }
     },
     "localname": "SeniorNotes2020Due2023Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2025",
        "label": "Senior Notes 2020 Due 2025 [Member]",
        "terseLabel": "0.000% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2020Due2025Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2028",
        "label": "Senior Notes 2020 Due 2028 [Member]",
        "terseLabel": "0.375% Senior Notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes2020Due2028Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2032",
        "label": "Senior Notes 2020 Due 2032 [Member]",
        "terseLabel": "0.750% Senior Notes due 2032"
       }
      }
     },
     "localname": "SeniorNotes2020Due2032Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2040",
        "label": "Senior Notes 2020 Due 2040 [Member]",
        "terseLabel": "1.375% Senior Notes due 2040"
       }
      }
     },
     "localname": "SeniorNotes2020Due2040Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2050",
        "label": "Senior Notes 2020 Due 2050 [Member]",
        "terseLabel": "1.625% Senior Notes due 2050"
       }
      }
     },
     "localname": "SeniorNotes2020Due2050Member",
     "nsuri": "http://www.medtronic.com/20220823",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "verboseLabel": "Ordinary shares, par value $0.0001 per share"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001613103-22-000034-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001613103-22-000034-xbrl.zip
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M^<@&U .H8":8)QES)T"O#DP;EBS8%WB]Y\'Z-/;5=400, _&^"]V@,H\YG0
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MP.+^&LP@@4SR$N#AR)%MU60/0'.P\J49IHD3<Z6U@1V8[=C*U%#&1#/7B@'
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MUMAB.2M8#M2.B_.:MB(A"--@X_/R3'^O$)R7^$S"^>RKRR,++T*;K/6PV5+
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MW>EHC;:\U#GK== U7=/UK:]"WGK:AE:M-7/-NOE9O;./M=9SWC%]C+7JK:+
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MZ=0'(LW [T!4H8!G/QI:C7536[@'PK0;B[47$)=H=F'\UY+X!15MWUN74UX
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M4*-384;5,+;Q^FRS\].#8*TJ(:AG8:5=E2L-;<MRQ)&<B/<C@;<=NWUVB<5
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MC^/K3SR7.9[;CX4L=E8DOU*>X$NFF@UR*QW<"B^R5ZDH,N7:QN1_UY))/<&
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MWOFT<;RUOC.$.2>K4\AGO<YWU]^11OL"NHQ1TG3,)DPV,4PVA= PV80&)>F
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ME%@DDF>E1.XQ4Y)(% 2E0,/:(!.D3=YA)[C6D=-828G+_6X8RZBH5]H$'JR
MIO2<A2B$Q3:P:FEC\1@NYJ2$=M[D/BUNL !2 KH$I$242'$%,SQ-E51J:976
MZ&520C]9CKXE?BLI<6/PSDH)(BSQ>>Z1\'D*M,QSI"S'".>*2>FI969RB"73
M3]<ML2">K;3$(J$\JR4TRPTH7XU">K\WU]PC&Y5$TN31VR"Y]95;XHJ-S;FU
MVJ8W_()>MCE6SG*&:;0A4F'5=U_)7&F)&V-X..^6D(S22'(DTNY/;BU'1BB*
M"(D">V6D(#ZM<%128L'PK:3$C;$[M\(1TOMO;8Z(932]_98AG4X_T<;@:'@>
M<Q6F4N+IGF2Y()JMI,0BH3SGEI"4Q<@<,A1;D!(B(!- &@<N<R&-QL282DI<
M[GK3,CB0QS)BS*//E9 D]\1(EP=)0JRDQ*(QW)@/E@"U0(%D+)*@>Q$WWB)K
M6#XZGC5GWE'J1L$2EVW<X/C)<O0M\5MIB1N#=U9+*.6MB9[ #,Y*Q)VU2,4@
M$ DACT93X:D8:PF.GZY;8D$\6VF)14)YWBU!!3;&HB 53.EPH$BG8[*)R7,?
MHM-$JTI+7+X_23IJ&(X4QBE.3+ XSWGP/B<:!#2ISI%8/(;GHR6"XC10QY!T
M+B+.5!PO/0<F6>3*129ETA*728FGZY:X)7PK*7%C[,Y*B1@\-\(+)$-ZV:TD
M'EFJ&6(N.F%UC-9.CI*H8'I;EJV4Q"*1/*LDN*1*TFB0B80 "S.&%'44&2Z-
M#!'ZS%=*XJKC4FA4,IUE2P.'QTV$>061P4!# M9QI206CN'Y8 EF0WIWL ,E
MD29VFA.DA<D!S3FC3FJOL+QJ)ZAXNEZ)6^*WDA(W!N^LE+ B9PKD+*)YBE;S
M(B)C:8Z\44[ -(Y0/_%*5#"]+<U64F*12)Z5$M$[)JP@*.<Z;<@7#&E"0%DX
M)BWP,W7A-KM!EP?&M@/\ZXLOJR]''^-;;+G\[?;S%Q<&88)G,,QG,4P3AC>[
M'DQI$#([S%PK0/TZ!JIZW J#5B@S^,C*L%?T!Z7I#K*BGT$1 U1X#TPTVRM[
MQX,6 +\#)1]F!H:G$"$+GQ7=;/NH'3*.1=:+HV0FD"Z@[&MND/Y*-&/9LW_^
M@^3R!66X]O5FR ;:^!!L_;<,1KY12B X$+T@K6EWG$F4?TV4X]J9Y\XD6\OF
MVG_:\E!_J!P"5EEAAX-%,\LUNV7CDB;^6NQK%FJM+$P[^] M7,^'K/[^=J6Z
MBO"<9@0SKK#0G*=W)(!(%]P0'G6@UGYO17>C.TAT-ZGVFU&M7XTK?8[W5F)Q
M$CS4K]U_F-KS(_?_^K.]2]M?['YO6(<R;34_X*UFNUW_E @LY=<HZIWM5AW*
MWWBSW6YT&NU&6J%==_2S5S$*Z2-,W-.:K,HQLE)K%+VR3GJ8M.9 6?_\AY:<
MO[B,HNX#T?,&]RNR8;R"WYX#JUU(ED6<Y<D64&%H!S< *NSV!MF@EQWUP^@N
M,)C0]?#W=&<?.*S7S0ZAM#V?8#[*JSU,F1\7D'6R^2[4#:Z4X4O1A^> 8$W7
M);,VSO6.P&[@YO[ =+TI?3\[+'M?BI3^X5'9/TJ%@<R!+T<9$?;,_#8ET;/,
M6;MG9OD*V)MCY)*+TRI,LN&T)@44Y; W;O.5,K3-H/@27AP7?M":*KHS#]K>
M8-#KK.!OCQC;[[6/!O./7%Z0LY^M\IO$W0O(EL$<(!-A.%HQ[6,S["\MGQ^(
M8!2:*?U-,QY]C%3(MUJ5/I0(.K9M#OMA9?KEA2_ZAVTS7"FZH]X9/?1B,A9.
MFB*58%9[)W$^OCPIG-8U)5@JW\23,LEX4O3:J.A3^7_N&CRH+K\*(_FEUZY*
M5<F:IM=+]L?]/^T0YYMF\=.2.6.Z>%ZR.0B=)(#P"UK#M':[.=>O5;7MT#]J
M#_J)PK: -4VRRZ1)??;Z*RV^Z@%-IPO74.07B#XQK3^P/<PW5R@?V=[2M=CF
M?#KW)!ZWNMG:T=Y1?Y!1]CP=/DJ?9_7@!V4/V#H[;+OGF8'AP;;A5[OH%&F4
MF@K,7KEGNI"7SXZ@^N,)0-L<CUI\,W%FU\,XV.\?P1V02!GZ?1B9VL' \&:Z
M71B/7!J/"NBC6)10A/\<F1(H#G[U 4#9,)AR])+8,^-8.>[46K8&Q3@<3L>G
M\XF#>(]'9;?HMU+.2?>W"EL,,N ;DH:XD;POPV&O'-3N7$WP:PYJR0:GA:EH
M^,G2L*YA\JAH>%RMJS\G!MJO_3 -WQ-]/O._96]!R2<>FE;BWHR8YOI'C)CP
MFAZ;_T*M6-=R<?F3/YJJ!)FB\WO@AG%C+QIFZEHF-$'6V%9@@FY#N7B&^#D5
MG#.C.8ZX1LTFQC0Q#ZA;!I.MPF?3<OZ2-;^X:]=#WY7%X<42=/!U%CAY)A\1
MW96-DOCP\A;!J3V6+FC<? XVYVZ]BW'V*JT5X]V0-K3YN' ^N-YX2K R$J_I
M+BB3F98EK9D@N+$T;K 2QO;WXMX+F+7*Y$"=E$=K@N*0LO\0$,I=:/]^66L-
M ,A)Y[Y<-K/3_*=(%8M%9F TD%\9F?=6P&LB\Z]S\S0033-SS1%J'T=5O4ES
MY9G)]256^?"F,1<;)\'\!C9YZ6!TAP/+756?"*C^JQZ4)_O+[(5L,T4? &R+
M+R%;-P.3O2Y@,O L@';SR>,^\M@GS\7F2/=G?_^Q_3;S/7?4"=W!;[7+,'*S
MV="/.*#NX)FYJ(P[?>RI._&_UWP_<?X_FB*_WWS36&M^V-YX?QU0Z7N;RO]U
M9@ULO$3WGZ.B#,D>^]>,)7@^NFG[_-J>/VH/,V>.TGK<&<=CRL:&K _] Q=Z
MW9$;U(:6:<>T9)@2&@TYDQM:H0Q'77AFE)PY&K1Z97*]WKG_<C:\Z3&Y+YFH
M,7$]9\)-KM$:X73AG@]6$THLWM=:(Y0O/%5:TUH_E';50+772_;B23D15\S*
M?T#K/(5;KREX%Z\0[W_J>J\"N:K^PZG^O=;IFA.^<]/W:S@P;\>5WW%2WLVM
M%555MOIKU^F:MOK'\*%4Z'X[Z?[<9\O]Y>S?I@S=[&TM^\N4!ZVBW5[0ML-?
MJZ;K9A!6YIVC3QJ>3YQ"GVCUK[5L^Q"&EX40UQ,%057]JOH/P\HW3H([&JUJ
M?2Q<R-)Z;I%"GT=QU:]:18AGHJNW8H2;RGDB^)'=CK?9V%$M)3VPI:1+=CK^
M_:_-/S:;V69C?>/O"Y#P4-8=B*B1.XB-U#6AU.(C+DE-Y]<K;!5Q^0M6L(JX
MK"(NJXC+*N+R849<5LB\VXC+&P1<_NHUS:J(RRKB\NXC+A_3,0/+MN>'\ _8
M3WOU_P-02P,$%     @ ZS4752QMV,N[ P  S18  !    !M9'0M,C R,C X
M,C,N>'-DU5AMC]HX$/Z^O\*7S^>\0DG00J7;54^5MKW3=JOV6^4X$[ VB7.V
ML]!_7]N0LD#*$O:DRTF()./G&<_C&4\,UV_798&>0$C&JYD3N+Z#H*(\8]5B
MYGQ^>(=CY^W\ZNKZ-XR__G%_AVXY;4JH%+H10!1D:,74$GW)0#ZB7/ 2?>'B
MD3T1C.>6=,/K[X(ME@J%?A@>CHII0""/]!<.(/+Q:!(0G([B#.?C-/<3G^9)
M2GY?3-.8C@#2#$]B&.-1.IK@9)1E.(EI0&.2T3=Y8IVNY532)90$:6&5G*[E
MS%DJ54\];[5:N:O(Y6+AA;X?>%\_W'VR4&>++5CUN(=>IZ)H\9%GAE,BH867
MF=I#EY IP2M&7<I+S\CUXS!JT<87.^&=55*1BO[TKGUA];T&V<W1PYX9-O/X
MV ]P&#B(*"58VBAXQT5Y"SEI"AUB4_W3D(+E##*=W ),^O8 SX85$0M0'TD)
MLB84SM$WOT+(+#LK:RX4JHZX.9&IC;F1>$%(;:D.VJ3ICE.B;.T9M-1P*[&3
MXT&A9&O!QN*N9>9X+T;P+/-!DB3>VJ2R.X+.W%@\-K<X"'$4])CV5TD^?V[]
MA%O>OQ'#KHS[Q=#R7AE#9^'^JA9>8MIG>688UI$$ZB[XDY<!.Z<.#^'FIJ/R
M2%5Q9?G&LK75-:MROC%HDUF_:;N(]Y"W?>&HZW14JKU,B:""%R^4M5<+7H-0
M#.3SCF4=+ 7D,T?W+=SNWF\%25T=2(LX\K]?"&;8TQ0H[G9"6J[)Q<R1>OT+
MV"S-@'77 OKJUA2I6Z=-\_]=?@9Y7_F:PBIV@7C#?M#CB&4SYX;KPX:#C.WS
M_?L3[Q<[YP;=NFL=[B*9^_I%KC\([PXF&%G6M7>(/?#22,C^JN;V_C"U6_(6
M<H)(24&;HC]O?S$[:5MCNWK;QN+M=Y;-\U[W,;UG^Y:W*Z[S_NT35(R+CUR!
M-,WSM@%]&7^ ,C7)(*E4@E!]$E"BT55C6N?,.<VI6*'[@*F:#<<>;Z:Z AG/
M'FPQ9(VP,>D.V^@)F&K,TY^"-_7,V<"9@E*?.3;P]KPSS7A)6/5>CQE'NR9[
MCJB1WU_4CC-04>,+1(T'*RI(;(!1$KKAV/\;!-70'@)/\H<FMMTWT05[+1JJ
MJ)\9"-Q7);"#/E"I8>2[T61\L=9N_E#%AA<(#(<J:KN;HCZBCCA#$]5NH2!P
M_5?LP"[ZT*2VW3"^H(/&0Q7U+ %OPLO;2C=_H&)'27^!.\Y 1?4Z1!]QABIJ
M<H&HR7\BRO[^V?R#,[_Z 5!+ P04    " #K-1=5<-#YC@4+   ]6   %
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M$+NFKLIP$NKY9('OK/[X5W#-%[(YIX:+A?SE]Q[(18++JNQCQEO\N/IR+^(
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MM$P[(#;I@%$&,6'?5Y"".T85M@R>'SJ#US*.A]4<XPUY^F6?NZFUNVGADY*
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M+)MF<^4,GR.@LLPBG!F-N/(S_,,!1FKR3T(FI92^EGX$8E<;#X=F&.ONBDJ
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MCN$SIX<Y$O9K8:9S67Q+EA^DZ_=Y\BB+Y+.<N47MWZK0"B:/MEC_U?-0Z G
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MQ&. */8-B#Y"C@F(-=AFY4?,11)4(8$6I!"5T!JL=PXT2VB,4TZ@VC9"F$<
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MVZ(?#5]:&[A9< <K5^U QI$L/U7%997>+-)KW^)4%"%P$3PP)[JM5" 55"B
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MVPN.6^8VXV%?CD>W5W)G"/QP=$])\NO3RV>K%[J;[J?&7S[[/U!+ 0(4 Q0
M   ( .LU%U4[)J&?(6@  .04"  >              "  0    !E>&AI8FET
M.3DQ+69Y,C-Q,65A<FYI;F=S<BYH=&U02P$"% ,4    " #K-1=5C]Q46E@B
M  !V3 $ $               @ %=:   ;61T+3(P,C(P.#(S+FAT;5!+ 0(4
M Q0    ( .LU%U4L;=C+NP,  ,T6   0              "  >.*  !M9'0M
M,C R,C X,C,N>'-D4$L! A0#%     @ ZS4757#0^8X%"P  /5@  !0
M         ( !S(X  &UD="TR,#(R,#@R,U]D968N>&UL4$L! A0#%     @
MZS4757[@QD;B$@  M<4  !0              ( ! YH  &UD="TR,#(R,#@R
M,U]L86(N>&UL4$L! A0#%     @ ZS475=$T^Q^Z"@  .%X  !0
M     ( !%ZT  &UD="TR,#(R,#@R,U]P<F4N>&UL4$L%!@     &  8 C@$
'  .X      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
